Cholesterol	cholesterol	NN	O
is	be	VBZ	O
a	a	DT	O
vital	vital	JJ	O
component	component	NN	O
of	of	IN	O
cell	cell	NN	O
membranes	membrane	NNS	O
,	,	,	O
essential	essential	JJ	O
for	for	IN	O
the	the	DT	O
synthesis	synthesis	NN	O
of	of	IN	O
steroid	steroid	NNP	O
hormones	hormones	NNPS	O
,	,	,	O
bile	bile	NN	O
acids	acid	NNS	O
,	,	,	O
and	and	CC	O
vitamin	vitamin	NN	O
D	d	NN	O
,	,	,	O
but	but	CC	O
high	high	JJ	O
cholesterol	cholesterol	NN	O
levels	level	NNS	O
are	be	VBP	O
associated	associate	VBN	O
with	with	IN	O
an	an	DT	O
elevated	elevated	JJ	O
risk	risk	NN	O
of	of	IN	O
cardiovascular	cardiovascular	JJ	O
diseases	disease	NNS	O
.	.	.	O

Cholesterol	cholesterol	NN	O
is	be	VBZ	O
the	the	DT	O
end	end	NN	O
-	-	HYPH	O
product	product	NN	O
of	of	IN	O
the	the	DT	O
mevalonate	mevalonate	NN	O
pathway	pathway	JJ	B
.	.	.	O

The	the	DT	O
enzyme	enzyme	NNS	O
3-hydroxy-3-methylglutaryl	3-hydroxy-3-methylglutaryl	CD	O
coenzyme	coenzyme	NNS	O
A	a	DT	O
reductase	reductase	NN	O
is	be	VBZ	O
the	the	DT	O
rate	rate	NN	O
-	-	HYPH	O
limiting	limit	VBG	O
step	step	NN	O
in	in	IN	O
the	the	DT	O
synthesis	synthesis	NN	O
of	of	IN	O
cholesterol	cholesterol	NN	O
and	and	CC	O
it	-PRON-	PRP	O
catalyses	catalyse	VBZ	O
the	the	DT	O
conversion	conversion	NN	O
of	of	IN	O
HMG	HMG	NNP	O
-	-	HYPH	O
CoA	CoA	NNP	O
to	to	TO	O
mevalonate	mevalonate	VB	O
;	;	:	O
the	the	DT	O
mevalonate	mevalonate	NN	O
pathway	pathway	NN	O
and	and	CC	O
the	the	DT	O
HMG	HMG	NNP	O
-	-	HYPH	O
CoA	CoA	NNP	O
enzyme	enzyme	NNS	O
,	,	,	O
as	as	RB	O
well	well	RB	O
as	as	IN	O
its	-PRON-	PRP$	O
regulation	regulation	NN	O
are	be	VBP	O
conserved	conserve	VBN	O
from	from	IN	O
yeast	yeast	NN	O
to	to	IN	O
humans	human	NNS	B
,	,	,	B
.	.	.	O

HMG	HMG	NNP	O
-	-	HYPH	O
CoA	CoA	NNP	O
is	be	VBZ	O
the	the	DT	O
target	target	NN	O
of	of	IN	O
statins	statin	NNS	B
,	,	,	O
the	the	DT	O
most	most	RBS	O
prescribed	prescribed	JJ	O
drug	drug	NN	O
class	class	NN	O
for	for	IN	O
lowering	lower	VBG	O
elevated	elevate	VBN	O
LDL	ldl	NN	O
-	-	HYPH	O
cholesterol	cholesterol	NN	O
,	,	,	O
generally	generally	RB	O
effective	effective	JJ	O
and	and	CC	O
well	well	RB	O
tolerated	tolerate	VBN	O
;	;	:	O
however	however	RB	O
,	,	,	O
patients	patient	NNS	O
can	can	MD	O
experience	experience	VB	O
muscle	muscle	NN	O
adverse	adverse	JJ	O
effects	effect	NNS	O
such	such	JJ	O
as	as	IN	O
myopathy	myopathy	JJ	B
,	,	,	B
.	.	.	O

Genetic	genetic	JJ	O
factors	factor	NNS	B
and	and	CC	O
drug	drug	NN	O
-	-	HYPH	O
drug	drug	NN	O
interactions	interaction	NNS	B
also	also	RB	O
contribute	contribute	VBP	O
as	as	IN	O
risk	risk	NN	O
factors	factor	NNS	O
for	for	IN	O
the	the	DT	O
development	development	NN	O
of	of	IN	O
muscle	muscle	NN	O
side	side	NN	O
effects	effect	NNS	O
in	in	IN	O
patients	patient	NNS	B
,	,	,	B
.	.	.	O

Mitochondrial	mitochondrial	NN	O
dysfunction	dysfunction	NN	O
has	have	VBZ	O
been	be	VBN	O
described	describe	VBN	O
as	as	IN	O
responsible	responsible	JJ	O
for	for	IN	O
several	several	JJ	O
statins	statin	NNS	O
side	side	NN	O
effects	effect	NNS	O
and	and	CC	O
serious	serious	JJ	O
adverse	adverse	JJ	O
reactions	reaction	NNS	O
;	;	:	O
in	in	IN	O
particular	particular	JJ	O
,	,	,	O
various	various	JJ	O
mitochondrial	mitochondrial	NN	O
phenotypes	phenotype	NNS	O
were	be	VBD	O
described	describe	VBN	O
such	such	JJ	O
as	as	IN	O
the	the	DT	O
decrease	decrease	NN	O
of	of	IN	O
respiratory	respiratory	JJ	O
chain	chain	NN	O
function	function	NN	O
,	,	,	O
alteration	alteration	NN	O
of	of	IN	O
calcium	calcium	NN	O
homeostasis	homeostasis	NN	O
,	,	,	O
ROS	ros	NN	O
production	production	NN	O
,	,	,	O
alteration	alteration	NN	O
of	of	IN	O
mitochondrial	mitochondrial	NN	O
volume	volume	NN	O
,	,	,	O
however	however	RB	O
,	,	,	O
the	the	DT	O
primary	primary	JJ	O
effect	effect	NN	O
of	of	IN	O
statins	statin	NNS	O
remains	remain	VBZ	O
to	to	TO	O
be	be	VB	O
elucidated	elucidate	VBN	B
,	,	,	B
.	.	.	O

The	the	DT	O
activity	activity	NN	O
of	of	IN	O
statins	statin	NNS	O
was	be	VBD	O
investigated	investigate	VBN	O
previously	previously	RB	O
in	in	IN	O
the	the	DT	O
yeast	yeast	NN	O
Candida	Candida	NNP	O
glabrata	glabrata	VBP	B
and	and	CC	O
in	in	IN	O
Saccharomyces	saccharomyce	NNS	O
cerevisiae	cerevisiae	VBZ	B
;	;	:	O
the	the	DT	O
yeast	yeast	NN	O
S.	S.	NNP	O
cerevisiae	cerevisiae	NNS	O
is	be	VBZ	O
an	an	DT	O
excellent	excellent	JJ	O
unicellular	unicellular	JJ	O
model	model	NN	O
to	to	TO	O
gain	gain	VB	O
insights	insight	NNS	O
into	into	IN	O
human	human	JJ	O
diseases	disease	NNS	B
CYTOWANIE	cytowanie	VB	B
in	in	IN	O
particular	particular	JJ	O
,	,	,	O
those	those	DT	O
resulting	result	VBG	O
from	from	IN	O
impaired	impaired	JJ	O
mitochondrial	mitochondrial	NN	O
function	function	NN	B
,	,	,	O
because	because	IN	O
S.	S.	NNP	O
cerevisiae	cerevisiae	NNS	O
is	be	VBZ	O
able	able	JJ	O
,	,	,	O
utilising	utilise	VBG	O
fermentable	fermentable	JJ	O
carbon	carbon	NN	O
sources	source	NNS	O
to	to	TO	O
survive	survive	VB	O
without	without	IN	O
mitochondrial	mitochondrial	NN	O
respiration	respiration	NN	O
.	.	.	O

We	-PRON-	PRP	O
previously	previously	RB	O
demonstrated	demonstrate	VBD	O
that	that	IN	O
ketoconazole	ketoconazole	NNP	O
,	,	,	O
which	which	WDT	O
blocks	block	VBZ	O
the	the	DT	O
ergosterol	ergosterol	JJ	O
biosynthetic	biosynthetic	JJ	O
pathway	pathway	NN	O
downstream	downstream	NN	O
the	the	DT	O
HMG	HMG	NNP	O
-	-	HYPH	O
CoA	CoA	NNP	O
reductase	reductase	NN	O
,	,	,	O
reduced	reduce	VBD	O
the	the	DT	O
ergosterol	ergosterol	JJ	O
content	content	NN	O
in	in	IN	O
yeast	yeast	NN	O
cells	cell	NNS	O
and	and	CC	O
induced	induce	VBD	O
the	the	DT	O
loss	loss	NN	O
of	of	IN	O
mitochondrial	mitochondrial	NN	O
DNA	dna	NN	O
;	;	:	O
this	this	DT	O
phenomenon	phenomenon	NN	O
is	be	VBZ	O
coupled	couple	VBN	O
with	with	IN	O
a	a	DT	O
re	re	NN	O
-	-	NN	O
localisation	localisation	NN	O
of	of	IN	O
Erg27	Erg27	NNP	O
enzyme	enzyme	NNS	O
from	from	IN	O
Lipid	Lipid	NNP	O
Droplets	Droplets	NNPS	O
to	to	IN	O
Endoplasmic	Endoplasmic	NNP	O
Reticulum	Reticulum	NNP	B
.	.	.	O

Here	here	RB	O
,	,	,	O
we	-PRON-	PRP	O
expand	expand	VBP	O
the	the	DT	O
analysis	analysis	NN	O
of	of	IN	O
mitochondrial	mitochondrial	NN	O
function	function	NN	O
and	and	CC	O
the	the	DT	O
stability	stability	NN	O
of	of	IN	O
mitochondrial	mitochondrial	NN	O
DNA	dna	NN	O
using	use	VBG	O
statins	statin	NNS	O
in	in	IN	O
S.	S.	NNP	O
cerevisiae	cerevisiae	NNS	O
:	:	:	O
we	-PRON-	PRP	O
showed	show	VBD	O
that	that	IN	O
these	these	DT	O
molecules	molecule	NNS	O
cause	cause	VBP	O
a	a	DT	O
reduction	reduction	NN	O
of	of	IN	O
ergosterol	ergosterol	NN	O
,	,	,	O
inducing	induce	VBG	O
loss	loss	NN	O
of	of	IN	O
mitochondrial	mitochondrial	NN	O
DNA	dna	NN	O
and	and	CC	O
resulting	result	VBG	O
in	in	IN	O
a	a	DT	O
reduction	reduction	NN	O
of	of	IN	O
mitochondrial	mitochondrial	NN	O
respiration	respiration	NN	O
/	/	SYM	O
function	function	NN	O
coupled	couple	VBN	O
with	with	IN	O
the	the	DT	O
Erg27	Erg27	NNP	O
re	re	NN	O
-	-	NN	O
localisation	localisation	NN	O
in	in	IN	O
ER	ER	NNP	O
.	.	.	O

In	in	IN	O
murine	murine	NN	O
myoblasts	myoblast	NNS	O
,	,	,	O
upon	upon	IN	O
statins	statin	NNS	O
treatment	treatment	NN	O
,	,	,	O
we	-PRON-	PRP	O
also	also	RB	O
observed	observe	VBD	O
a	a	DT	O
reduction	reduction	NN	O
of	of	IN	O
mitochondrial	mitochondrial	JJ	O
DNA	dna	NN	O
copy	copy	NN	O
number	number	NN	O
associated	associate	VBN	O
with	with	IN	O
an	an	DT	O
impaired	impaired	JJ	O
differentiation	differentiation	NN	O
capacity	capacity	NN	O
.	.	.	O

The	the	DT	O
strains	strain	NNS	O
used	use	VBN	O
in	in	IN	O
this	this	DT	O
study	study	NN	O
:	:	:	O
the	the	DT	O
S.	S.	NNP	O
cerevisiae	cerevisiae	VBZ	O
W303	W303	NNP	O
MAT	MAT	NNP	O
a	a	NNP	O
,	,	,	O
his3â11	his3â11	NNP	O
,	,	,	O
ade2â1	ade2â1	NN	O
,	,	,	O
leu2â3	leu2â3	NNP	O
,	,	,	O
â112	â112	NNP	O
,	,	,	O
ura3â1	ura3â1	JJ	O
,	,	,	O
trp1â1	trp1â1	NNP	O
,	,	,	O
can1â100	can1â100	NNP	O
,	,	,	O
W303-ERG27-GFP	W303-ERG27-GFP	VBZ	O
,	,	,	O
MValC25	MValC25	NNP	O
T	T	NNP	O
MATa	MATa	NNS	O
,	,	,	O
ade2â1	ade2â1	NN	O
,	,	,	O
ura3â52	ura3â52	NN	O
,	,	,	O
leu2	leu2	NNP	O
,	,	,	O
kar1â1	kar1â1	NNP	O
,	,	,	O
syn	syn	NNP	O
;	;	:	O
the	the	DT	O
K.	K.	NNP	O
lactis	lactis	JJ	O
PM6	PM6	NNP	O
-	-	HYPH	O
7A	7A	NNP	O
,	,	,	O
PM6	PM6	NNP	O
-	-	HYPH	O
7A	7A	NNP	O
/	/	SYM	O
Îpda1	îpda1	NN	O
.	.	.	O

The	the	DT	O
plasmid	plasmid	NN	O
pVT100U	pVT100U	NNP	O
-	-	HYPH	O
mitoGFP	mitoGFP	NNP	O
was	be	VBD	O
used	use	VBN	O
to	to	TO	O
visualise	visualise	VB	O
mitochondria	mitochondrion	NNS	O
.	.	.	O

Yeast	yeast	NN	O
culture	culture	NN	O
media	medium	NNS	O
:	:	:	O
YPD	YPD	NNP	O
,	,	,	O
was	be	VBD	O
used	use	VBN	O
as	as	IN	O
rich	rich	JJ	O
medium	medium	NN	O
.	.	.	O

YPG	YPG	NNP	O
,	,	,	O
was	be	VBD	O
the	the	DT	O
medium	medium	NN	O
used	use	VBN	O
to	to	TO	O
verify	verify	VB	O
the	the	DT	O
respiratory	respiratory	JJ	O
competence	competence	NN	O
of	of	IN	O
yeast	yeast	NN	O
colonies	colony	NNS	O
.	.	.	O

All	all	DT	O
media	medium	NNS	O
were	be	VBD	O
supplemented	supplement	VBN	O
with	with	IN	O
2.3	2.3	CD	O
%	%	NN	O
bacto	bacto	DT	O
agar	agar	NN	O
for	for	IN	O
solid	solid	JJ	O
media	medium	NNS	O
.	.	.	O

YPD	YPD	NNP	O
medium	medium	NN	O
supplemented	supplement	VBD	O
with	with	IN	O
0.5âmg	0.5âmg	NNS	O
/	/	SYM	O
ml	ml	NN	O
of	of	IN	O
ergosterol	ergosterol	NN	O
.	.	.	O

Ergosterol	ergosterol	UH	O
and	and	CC	O
Tween	Tween	NNP	O
80	80	CD	O
were	be	VBD	O
dissolved	dissolve	VBN	O
in	in	IN	O
pure	pure	JJ	O
ethanol	ethanol	NN	O
to	to	IN	O
final	final	JJ	O
concentration	concentration	NN	O
of	of	IN	O
10âmg	10âmg	CD	O
/	/	SYM	O
ml	ml	NNS	O
for	for	IN	O
ergosterol	ergosterol	NN	O
and	and	CC	O
42	42	CD	O
%	%	NN	O
for	for	IN	O
Tween80	Tween80	NNP	O
,	,	,	O
and	and	CC	O
steamed	steam	VBD	O
at	at	IN	O
100âÂ	100ââ	CD	O
°	°	,	O
C	C	NNP	O
for	for	IN	O
10âmin	10âmin	NNP	O
,	,	,	O
always	always	RB	O
protected	protect	VBN	O
from	from	IN	O
light	light	NN	O
,	,	,	O
before	before	IN	O
being	be	VBG	O
added	add	VBN	O
to	to	IN	O
the	the	DT	O
medium	medium	NN	O
.	.	.	O

Yeast	yeast	NN	O
cultures	culture	NNS	O
were	be	VBD	O
grown	grow	VBN	O
and	and	CC	O
analysed	analyse	VBN	O
in	in	IN	O
exponential	exponential	JJ	O
phase	phase	NN	O
at	at	IN	O
28âÂ	28ââ	CD	O
°	°	,	O
C	C	NNP	O
,	,	,	O
unless	unless	IN	O
otherwise	otherwise	RB	O
specified	specify	VBN	O
.	.	.	O

C2C12	C2C12	NNP	O
myoblasts	myoblast	NNS	O
were	be	VBD	O
grown	grow	VBN	O
at	at	IN	O
5	5	CD	O
%	%	NN	O
CO2	CO2	NNP	O
and	and	CC	O
37	37	CD	O
Â	â	NN	O
°	°	NN	O
C	C	NNP	O
in	in	IN	O
Dulbeccoâs	Dulbeccoâs	NNP	O
modified	modify	VBN	O
Eagleâs	eagleâs	CD	O
medium	medium	NN	O
supplemented	supplement	VBN	O
with	with	IN	O
1	1	CD	O
%	%	NN	O
penicillin	penicillin	NN	O
/	/	SYM	O
streptomycin	streptomycin	NN	O
and	and	CC	O
10	10	CD	O
%	%	NN	O
foetal	foetal	JJ	O
bovine	bovine	NN	O
serum	serum	NN	O
.	.	.	O

To	to	TO	O
induce	induce	VB	O
differentiation	differentiation	NN	O
,	,	,	O
cells	cell	NNS	O
were	be	VBD	O
cultured	culture	VBN	O
with	with	IN	O
Dulbeccoâs	dulbeccoâs	CD	O
modified	modify	VBN	O
Eagleâs	eagleâs	CD	O
medium	medium	NN	O
and	and	CC	O
2	2	CD	O
%	%	NN	O
horse	horse	NN	O
serum	serum	NN	O
for	for	IN	O
48âh	48âh	CD	O
,	,	,	O
when	when	WRB	O
more	more	JJR	O
than	than	IN	O
90	90	CD	O
%	%	NN	O
of	of	IN	O
the	the	DT	O
cells	cell	NNS	O
had	have	VBD	O
fused	fuse	VBN	O
into	into	IN	O
myotubes	myotube	NNS	O
.	.	.	O

C2C12	C2C12	NNP	O
were	be	VBD	O
treated	treat	VBN	O
for	for	IN	O
48	48	CD	O
with	with	IN	O
25uM	25um	CD	O
Atorvastatin	Atorvastatin	NNP	O
in	in	IN	O
growth	growth	NN	O
medium	medium	NN	O
and	and	CC	O
then	then	RB	O
induced	induce	VBN	O
to	to	TO	O
differentiate	differentiate	VB	O
for	for	IN	O
further	further	JJ	O
48âh	48âh	CD	O
either	either	CC	O
in	in	IN	O
the	the	DT	O
presence	presence	NN	O
or	or	CC	O
absence	absence	NN	O
of	of	IN	O
the	the	DT	O
compound	compound	NN	O
.	.	.	O

Strains	Strains	NNP	O
devoid	devoid	JJ	O
of	of	IN	O
mitochondrial	mitochondrial	NN	O
DNA	DNA	NNP	O
were	be	VBD	O
produced	produce	VBN	O
as	as	IN	O
follows	follow	VBZ	O
:	:	:	O
cells	cell	NNS	O
were	be	VBD	O
grown	grow	VBN	O
at	at	IN	O
the	the	DT	O
density	density	NN	O
of	of	IN	O
1âÃâ106cells	1âÃâ106cells	NNP	O
/	/	SYM	O
ml	ml	NN	O
on	on	IN	O
YPD	YPD	NNP	O
medium	medium	NN	O
,	,	,	O
phosphate	phosphate	NN	O
buffer	buffer	NN	O
pH	pH	NNP	O
6.5	6.5	CD	O
was	be	VBD	O
added	add	VBN	O
in1âml	in1âml	NNP	O
of	of	IN	O
culture	culture	NN	O
,	,	,	O
at	at	IN	O
the	the	DT	O
final	final	JJ	O
concentration	concentration	NN	O
of	of	IN	O
0.05âM	0.05âm	CD	O
,	,	,	O
and	and	CC	O
ethidium	ethidium	NN	O
bromide	bromide	NN	O
at	at	IN	O
final	final	JJ	O
concentration	concentration	NN	O
of	of	IN	O
50âÎ¼g	50âî¼g	NN	O
/	/	SYM	O
ml	ml	NNS	O
.	.	.	O

The	the	DT	O
cultures	culture	NNS	O
were	be	VBD	O
incubated	incubate	VBN	O
at	at	IN	O
28âÂ	28ââ	CD	O
°	°	,	O
C	C	NNP	O
for	for	IN	O
24âh	24âh	CD	O
.	.	.	O

Cells	cell	NNS	O
were	be	VBD	O
washed	wash	VBN	O
twice	twice	RB	O
,	,	,	O
plated	plate	VBN	O
on	on	IN	O
YPD	YPD	NNP	O
and	and	CC	O
incubated	incubate	VBD	O
at	at	IN	O
28âÂ	28ââ	CD	O
°	°	,	O
C	C	NNP	O
.	.	.	O

The	the	DT	O
absence	absence	NN	O
of	of	IN	O
mitochondrial	mitochondrial	NN	O
DNA	dna	NN	O
was	be	VBD	O
assessed	assess	VBN	O
by	by	IN	O
DAPI	dapi	NN	O
staining	staining	NN	O
and	and	CC	O
absence	absence	NN	O
of	of	IN	O
growth	growth	NN	O
on	on	IN	O
glycerol	glycerol	NN	O
containing	contain	VBG	O
medium	medium	NN	O
as	as	IN	O
a	a	DT	O
carbon	carbon	NN	O
source	source	NN	O
.	.	.	O

The	the	DT	O
cells	cell	NNS	O
were	be	VBD	O
pre	pre	VBN	O
-	-	VBN	O
activated	activated	JJ	O
in	in	IN	O
YPD	YPD	NNP	O
and	and	CC	O
YPD	YPD	NNP	O
rich	rich	JJ	O
medium	medium	NN	O
supplemented	supplement	VBN	O
with	with	IN	O
different	different	JJ	O
statin	statin	NN	O
up	up	IN	O
to	to	IN	O
the	the	DT	O
stationary	stationary	JJ	O
phase	phase	NN	O
.	.	.	O

Subsequently	subsequently	RB	O
,	,	,	O
the	the	DT	O
cultures	culture	NNS	O
were	be	VBD	O
all	all	RB	O
diluted	dilute	VBN	O
to	to	IN	O
a	a	DT	O
concentration	concentration	NN	O
of	of	IN	O
104	104	CD	O
cells	cell	NNS	O
/	/	SYM	O
ml	ml	NN	O
with	with	IN	O
the	the	DT	O
respective	respective	JJ	O
media	medium	NNS	O
and	and	CC	O
incubated	incubate	VBD	O
at	at	IN	O
28âÂ	28ââ	CD	O
°	°	,	O
C	C	NNP	O
.	.	.	O

The	the	DT	O
growth	growth	NN	O
trend	trend	NN	O
was	be	VBD	O
monitored	monitor	VBN	O
with	with	IN	O
the	the	DT	O
measurement	measurement	NN	O
of	of	IN	O
the	the	DT	O
optical	optical	JJ	O
density	density	NN	O
OD600	OD600	NNP	O
and/or	and/or	CC	O
with	with	IN	O
the	the	DT	O
cell	cell	NN	O
count	count	NN	O
with	with	IN	O
the	the	DT	O
BÃ¼rker	bã¼rker	NN	O
chamber	chamber	NN	O
.	.	.	O

Cells	cell	NNS	O
were	be	VBD	O
grown	grow	VBN	O
in	in	IN	O
YPD	YPD	NNP	O
until	until	IN	O
the	the	DT	O
stationary	stationary	JJ	O
phase	phase	NN	O
.	.	.	O

At	at	IN	O
the	the	DT	O
concentration	concentration	NN	O
of	of	IN	O
1âÃâ107cells	1âÃâ107cells	NNP	O
/	/	SYM	O
ml	ml	NNS	O
and	and	CC	O
1âÃâ108cells	1âÃâ108cells	NNP	O
/	/	SYM	O
ml	ml	NNP	O
,	,	,	O
100	100	CD	O
cells	cell	NNS	O
were	be	VBD	O
spotted	spot	VBN	O
in	in	IN	O
YPD	YPD	NNP	O
plates	plate	NNS	O
and	and	CC	O
incubated	incubate	VBD	O
at	at	IN	O
28âÂ	28ââ	CD	O
°	°	,	O
C	C	NNP	O
.	.	.	O

After	after	IN	O
two	two	CD	O
days	day	NNS	O
,	,	,	O
colonies	colony	NNS	O
were	be	VBD	O
replicated	replicate	VBN	O
on	on	IN	O
YPG	YPG	NNP	O
plates	plate	NNS	O
.	.	.	O

The	the	DT	O
lack	lack	NN	O
of	of	IN	O
rhoÂ	rhoÂ	NNS	O
°	°	NN	O
cell	cell	NN	O
growth	growth	NN	O
was	be	VBD	O
assessed	assess	VBN	O
on	on	IN	O
glycerol	glycerol	NN	O
as	as	IN	O
the	the	DT	O
carbon	carbon	NN	O
source	source	NN	O
and	and	CC	O
the	the	DT	O
absence	absence	NN	O
of	of	IN	O
mtDNA	mtdna	NN	O
by	by	IN	O
4â²,6-diamidino-2-phenylindole	4â²,6-diamidino-2-phenylindole	CD	O
staining	staining	NN	O
.	.	.	O

Cells	cell	NNS	O
were	be	VBD	O
observed	observe	VBN	O
with	with	IN	O
a	a	DT	O
Zeiss	Zeiss	NNP	O
Axio	Axio	NNP	O
Imager	Imager	NNP	O
Z1	Z1	NNP	O
Fluorescence	Fluorescence	NNP	O
Microscope	Microscope	NNP	O
with	with	IN	O
AxioVision	AxioVision	NNP	O
4.8	4.8	CD	O
Digital	Digital	NNP	O
Image	Image	NNP	O
Processing	Processing	NNP	O
System	System	NNP	O
,	,	,	O
the	the	DT	O
objective	objective	JJ	O
lens	lens	NN	O
used	use	VBN	O
was	be	VBD	O
63Ã	63ã	CD	O
Oil	oil	NN	O
.	.	.	O

Filter	filter	NN	O
sets	set	NNS	O
:	:	:	O
38HE	38he	CD	O
,	,	,	O
43HE	43he	CD	O
.	.	.	O

Filters	filter	NNS	O
for	for	IN	O
GFP	GFP	NNP	O
470/40ânm	470/40ânm	CD	O
excitation	excitation	NN	O
and	and	CC	O
525/50ânm	525/50ânm	CD	O
emission	emission	NN	O
and	and	CC	O
DAPI	dapi	NN	O
,	,	,	O
were	be	VBD	O
used	use	VBN	O
Metamorph	Metamorph	NNP	O
software	software	NN	O
was	be	VBD	O
used	use	VBN	O
to	to	TO	O
deconvolute	deconvolute	VB	O
Z	z	NN	O
-	-	HYPH	O
series	series	NN	O
and	and	CC	O
treat	treat	VB	O
the	the	DT	O
images	image	NNS	B
.	.	.	O

Pravastatin	Pravastatin	NNP	O
and	and	CC	O
simvastatin	simvastatin	NNP	O
were	be	VBD	O
hydrolysed	hydrolyse	VBN	O
in	in	IN	O
ethanolic	ethanolic	JJ	O
NaOH	NaOH	NNP	O
15	15	CD	O
%	%	NN	O
ethanol	ethanol	NN	O
and	and	CC	O
0.25	0.25	CD	O
%	%	NN	O
NaOH	NaOH	NNP	O
at	at	IN	O
60âÂ	60ââ	RB	O
°	°	NNP	O
C	C	NNP	O
for	for	IN	O
1âh	1âh	CD	O
.	.	.	O

Atorvastatin	Atorvastatin	NNP	O
and	and	CC	O
rosuvastatin	rosuvastatin	NNP	O
were	be	VBD	O
dissolved	dissolve	VBN	O
in	in	IN	O
H2Odd	H2Odd	NNP	O
supplemented	supplement	VBN	O
with	with	IN	O
1	1	CD	O
%	%	NN	O
DMSO	DMSO	NNS	O
and	and	CC	O
0.9	0.9	CD	O
%	%	NN	O
NaCl	NaCl	NNP	O
.	.	.	O

Q10	Q10	NNP	O
was	be	VBD	O
hydrolysed	hydrolyse	VBN	O
in	in	IN	O
100	100	CD	O
%	%	NN	O
acetone	acetone	NN	O
.	.	.	O

Cells	cell	NNS	O
were	be	VBD	O
grown	grow	VBN	O
to	to	IN	O
a	a	DT	O
density	density	NN	O
of	of	IN	O
1âÃâ107cells	1âÃâ107cells	NNP	O
/	/	SYM	O
ml	ml	NNS	O
in	in	IN	O
YPD	YPD	NNP	O
rich	rich	JJ	O
medium	medium	NN	O
supplemented	supplement	VBN	O
with	with	IN	O
:	:	:	O
pravastatin	pravastatin	NNP	O
150âÂµg	150ââµg	CD	O
/	/	SYM	O
ml	ml	NNP	O
,	,	,	O
atorvastatin	atorvastatin	VB	O
100âÂµg	100ââµg	CD	O
/	/	SYM	O
ml	ml	NNP	O
,	,	,	O
rosuvastatin	rosuvastatin	NNP	O
50âÂµg	50âÂµg	NNP	O
/	/	SYM	O
ml	ml	NNP	O
and	and	CC	O
Q10	Q10	NNP	O
10	10	CD	O
,	,	,	O
50âÂµg	50âÂµg	NNP	O
/	/	SYM	O
ml	ml	NN	O
.	.	.	O

The	the	DT	O
cells	cell	NNS	O
treated	treat	VBN	O
were	be	VBD	O
used	use	VBN	O
for	for	IN	O
several	several	JJ	O
assays	assay	NNS	O
.	.	.	O

Dry	Dry	NNP	O
cell	cell	NN	O
pellets	pellet	NNS	O
were	be	VBD	O
deep	deep	RB	O
frozen	freeze	VBN	O
by	by	IN	O
immersion	immersion	NN	O
in	in	IN	O
liquid	liquid	JJ	O
nitrogen	nitrogen	NN	O
and	and	CC	O
quickly	quickly	RB	O
ground	grind	VBD	O
to	to	IN	O
a	a	DT	O
powder	powder	NN	O
using	use	VBG	O
an	an	DT	O
IKA	IKA	NNP	O
A11	A11	NNP	O
basic	basic	JJ	O
laboratory	laboratory	NN	O
mill	mill	NN	O
.	.	.	O

300âmg	300âmg	CD	O
of	of	IN	O
cell	cell	NN	O
pellet	pellet	NN	O
were	be	VBD	O
transferred	transfer	VBN	O
to	to	TO	O
glass	glass	VB	O
vials	vial	NNS	O
with	with	IN	O
10âml	10âml	CD	O
Folch	Folch	NNP	O
solvent	solvent	NN	O
containing	contain	VBG	O
0.01	0.01	CD	O
%	%	NN	O
butylated	butylate	VBN	O
hydroxytoluene	hydroxytoluene	NNP	O
followed	follow	VBN	O
by	by	IN	O
the	the	DT	O
addition	addition	NN	O
of10Î¼l	of10î¼l	JJ	O
of	of	IN	O
internal	internal	JJ	O
standard	standard	NN	O
19-hydroxy	19-hydroxy	CD	O
-	-	HYPH	O
cholesterol	cholesterol	NN	O
,	,	,	O
2âmg	2âmg	CD	O
/	/	SYM	O
ml	ml	NNS	O
in	in	IN	O
methanol	methanol	NN	O
as	as	IN	O
internal	internal	JJ	O
standards	standard	NNS	O
.	.	.	O

The	the	DT	O
homogenisation	homogenisation	NN	O
and	and	CC	O
extraction	extraction	NN	O
60âmin	60âmin	NN	O
were	be	VBD	O
carried	carry	VBN	O
out	out	RP	O
at	at	IN	O
room	room	NN	O
temperature	temperature	NN	O
.	.	.	O

The	the	DT	O
extracts	extract	NNS	O
were	be	VBD	O
evaporated	evaporate	VBN	O
under	under	IN	O
a	a	DT	O
stream	stream	NN	O
of	of	IN	O
N2then	N2then	NNP	O
the	the	DT	O
dry	dry	JJ	O
residue	residue	NN	O
was	be	VBD	O
dissolved	dissolve	VBN	O
in1âml	in1âml	NNP	O
hydrolysis	hydrolysis	NN	O
solution	solution	NN	O
containing	contain	VBG	O
5	5	CD	O
%	%	NN	O
KOH	KOH	NNP	O
in	in	IN	O
and	and	CC	O
subjected	subject	VBN	O
to	to	IN	O
saponification	saponification	NN	O
1âh	1âh	CD	O
,	,	,	O
80âÂ	80âÂ	NNP	O
°	°	,	O
C	C	NNP	O
.	.	.	O

The	the	DT	O
hydrolysed	hydrolyse	VBN	O
solution	solution	NN	O
was	be	VBD	O
extracted	extract	VBN	O
with	with	IN	O
0.5âml	0.5âml	NNP	O
distilled	distil	VBN	O
H2O	h2o	NN	O
and	and	CC	O
4âml	4âml	CD	O
diethyl	diethyl	NN	O
ether	ether	NN	O
.	.	.	O

The	the	DT	O
ether	ether	NN	O
phase	phase	NN	O
was	be	VBD	O
dried	dry	VBN	O
under	under	IN	O
a	a	DT	O
stream	stream	NN	O
of	of	IN	O
N2at	N2at	NNP	O
RT	RT	NNP	O
.	.	.	O

The	the	DT	O
samples	sample	NNS	O
were	be	VBD	O
then	then	RB	O
reconstituted	reconstitute	VBN	O
with	with	IN	O
25âÎ¼l	25âî¼l	CD	O
ethylacetate	ethylacetate	NN	O
and	and	CC	O
vortex	vortex	NN	O
mixed	mix	VBN	O
.	.	.	O

The	the	DT	O
fractions	fraction	NNS	O
to	to	TO	O
be	be	VB	O
analysed	analyse	VBN	O
were	be	VBD	O
converted	convert	VBN	O
to	to	IN	O
their	-PRON-	PRP$	O
trimethyl	trimethyl	NN	O
-	-	HYPH	O
silylated	silylate	VBN	O
derivatives	derivative	NNS	O
by	by	IN	O
heating	heat	VBG	O
with	with	IN	O
40âÎ¼l	40âî¼l	JJ	O
BSTFA	BSTFA	NNP	O
containing	contain	VBG	O
1	1	CD	O
%	%	NN	O
TMCS	TMCS	NNP	O
at	at	IN	O
70âÂ	70âÂ	NNP	O
°	°	,	O
C	C	NNP	O
for	for	IN	O
45âmin	45âmin	NNP	O
.	.	.	O

The	the	DT	O
sample	sample	NN	O
was	be	VBD	O
dried	dry	VBN	O
under	under	IN	O
a	a	DT	O
stream	stream	NN	O
of	of	IN	O
N2	N2	NNP	O
.	.	.	O

The	the	DT	O
residue	residue	NN	O
was	be	VBD	O
dissolved	dissolve	VBN	O
in200âml	in200âml	NNP	O
hexane	hexane	NNP	O
and	and	CC	O
the	the	DT	O
clear	clear	JJ	O
hexane	hexane	NN	O
phase	phase	NN	O
was	be	VBD	O
transferred	transfer	VBN	O
into	into	IN	O
a	a	DT	O
glass	glass	NN	O
vial	vial	NN	O
for	for	IN	O
GCâMS	gcâm	NNS	O
injection	injection	NN	O
.	.	.	O

GCâMS	gcâm	NNS	O
analyses	analysis	NNS	O
were	be	VBD	O
performed	perform	VBN	O
with	with	IN	O
an	an	DT	O
Agilent	Agilent	NNP	O
6850âA	6850âa	NN	O
gas	gas	NN	O
chromatograph	chromatograph	NN	O
coupled	couple	VBN	O
to	to	IN	O
a	a	DT	O
5973âN	5973ân	JJ	O
quadrupole	quadrupole	JJ	O
mass	mass	JJ	O
selective	selective	JJ	O
detector	detector	NN	O
.	.	.	O

Chromatographic	chromatographic	JJ	O
separations	separation	NNS	O
were	be	VBD	O
carried	carry	VBN	O
out	out	RP	O
with	with	IN	O
an	an	DT	O
Agilent	Agilent	NNP	O
HP5msfused	hp5msfuse	VBN	O
-	-	HYPH	O
silica	silica	NN	O
capillary	capillary	JJ	O
column	column	NN	O
30âmâÃâ0.25âmm	30âmâÃâ0.25âmm	NNP	O
i.d	i.d	NNP	O
.	.	NNP	O

coated	coat	VBD	O
with	with	IN	O
5%-phenyl-95%-dimethylpolysiloxane	5%-phenyl-95%-dimethylpolysiloxane	NNP	O
film	film	NN	O
thickness	thickness	NN	O
0.25âÎ¼m	0.25âî¼m	CD	O
as	as	IN	O
stationary	stationary	JJ	O
phase	phase	NN	O
.	.	.	O

Injection	injection	NN	O
mode	mode	NN	O
:	:	:	O
splitless	splitless	VB	O
at	at	IN	O
a	a	DT	O
temperature	temperature	NN	O
of	of	IN	O
280âÂ	280ââ	CD	O
°	°	,	O
C	C	NNP	O
.	.	.	O

Column	column	NN	O
temperature	temperature	NN	O
programme	programme	NN	O
:	:	:	O
120âÂ	120ââ	CD	O
°	°	,	O
C	C	NNP	O
1âmin	1âmin	CD	O
then	then	RB	O
to	to	IN	O
320âÂ	320ââ	CD	O
°	°	,	O
C	C	NNP	O
at	at	IN	O
a	a	DT	O
rate	rate	NN	O
of	of	IN	O
5âÂ	5ââ	CD	O
°	°	NNP	O
C	C	NNP	O
/	/	SYM	O
min	min	NNP	O
and	and	CC	O
held	hold	VBN	O
for	for	IN	O
5âmin	5âmin	CD	O
.	.	.	O

The	the	DT	O
carrier	carrier	NN	O
gas	gas	NN	O
was	be	VBD	O
helium	helium	VBN	O
at	at	IN	O
a	a	DT	O
constant	constant	JJ	O
flow	flow	NN	O
of	of	IN	O
1.0âml	1.0âml	CD	O
/	/	SYM	O
min	min	NN	O
.	.	.	O

The	the	DT	O
spectra	spectra	NNP	O
were	be	VBD	O
obtained	obtain	VBN	O
in	in	IN	O
the	the	DT	O
electron	electron	NNP	O
impact	impact	NN	O
mode	mode	NN	O
at	at	IN	O
70âeV	70âev	CD	O
ionisation	ionisation	NN	O
energy	energy	NN	O
;	;	,	O
ion	ion	NN	O
source	source	NN	O
280âÂ	280ââ	CD	O
°	°	,	O
C	C	NNP	O
;	;	,	O
ion	ion	NN	O
source	source	NN	O
vacuum10	vacuum10	NNP	O
-	-	HYPH	O
5âTorr	5âTorr	NNP	O
.	.	.	O

MS	MS	NNP	O
analysis	analysis	NN	O
was	be	VBD	O
performed	perform	VBN	O
simultaneously	simultaneously	RB	O
in	in	IN	O
TIC	TIC	NNP	O
and	and	CC	O
SIM	SIM	NNP	O
mode	mode	NN	O
.	.	.	O

For	for	IN	O
GC	GC	NNP	O
-	-	HYPH	O
SIM	SIM	NNP	O
-	-	HYPH	O
MS	MS	NNP	O
analysis	analysis	NN	O
,	,	,	O
ion	ion	NNP	O
m	m	NNP	O
/	/	SYM	O
z	z	NNP	O
363	363	CD	O
was	be	VBD	O
selected	select	VBN	O
for	for	IN	O
ergosterol	ergosterol	NN	O
and	and	CC	O
ion	ion	NN	O
m	m	NN	O
/	/	SYM	O
z	z	NNP	O
353	353	CD	O
was	be	VBD	O
selected	select	VBN	O
for	for	IN	O
the	the	DT	O
internal	internal	JJ	O
standard	standard	NN	O
.	.	.	O

Respiration	respiration	NN	O
studies	study	NNS	O
were	be	VBD	O
performed	perform	VBN	O
using	use	VBG	O
a	a	DT	O
Clark	Clark	NNP	O
oxygen	oxygen	NN	O
electrode	electrode	NN	O
as	as	IN	O
described	describe	VBN	O
in	in	IN	O
De	De	NNP	O
Luca	Luca	NNP	O
etÂ	etÂ	NNP	O
al	al	NNP	O
.	.	.	B
.	.	.	O

Cells	cell	NNS	O
1âÃâ108	1âãâ108	CD	O
were	be	VBD	O
collected	collect	VBN	O
,	,	,	O
washed	wash	VBN	O
with	with	IN	O
1âml	1âml	CD	O
sterile	sterile	JJ	O
water	water	NN	O
,	,	,	O
suspended	suspend	VBN	O
in	in	IN	O
1âml	1âml	CD	O
sodium	sodium	NN	O
phosphate	phosphate	NN	O
buffer	buffer	NN	O
10âmM	10âmm	CD	O
pH	pH	NNP	O
7.4	7.4	CD	O
containing	contain	VBG	O
4âg	4âg	CD	O
lâ1	lâ1	NNS	O
glucose	glucose	NN	O
and	and	CC	O
loaded	load	VBN	O
in	in	IN	O
the	the	DT	O
reaction	reaction	NN	O
vessel	vessel	NN	O
of	of	IN	O
the	the	DT	O
previously	previously	RB	O
calibrated	calibrate	VBN	O
oxygen	oxygen	NN	O
electrod	electrod	NN	B
.	.	.	O

For	for	IN	O
the	the	DT	O
immunofluorescence	immunofluorescence	NN	O
on	on	IN	O
C2C12	c2c12	JJ	O
cells	cell	NNS	O
were	be	VBD	O
fixed	fix	VBN	O
with	with	IN	O
4	4	CD	O
%	%	NN	O
paraformaldehyde	paraformaldehyde	NN	O
in	in	IN	O
PBS	PBS	NNP	O
for	for	IN	O
20âmin	20âmin	CD	O
at	at	IN	O
RT	RT	NNP	O
,	,	,	O
and	and	CC	O
permeabilized	permeabilize	VBD	O
with	with	IN	O
0.5	0.5	CD	O
%	%	NN	O
Triton	Triton	NNP	O
X-100	X-100	NNP	O
in	in	IN	O
PBS	PBS	NNP	O
.	.	.	O

After	after	IN	O
1âh	1âh	CD	O
incubation	incubation	NN	O
with	with	IN	O
blocking	blocking	NN	O
solution	solution	NN	O
,	,	,	O
primary	primary	JJ	O
antibody	antibody	NN	O
for	for	IN	O
MyHC	MyHC	NNP	O
was	be	VBD	O
incubated	incubate	VBN	O
overnight	overnight	RB	O
at	at	IN	O
4âÂ	4ââ	CD	O
°	°	,	O
C	C	NNP	O
.	.	.	O

A	a	DT	O
goat	goat	NN	O
anti	anti	JJ	O
-	-	JJ	O
mouse	mouse	JJ	O
secondary	secondary	JJ	O
antibody	antibody	NN	O
coupled	couple	VBN	O
to	to	IN	O
Alexa	Alexa	NNP	O
Fluor	Fluor	NNP	O
488	488	CD	O
was	be	VBD	O
then	then	RB	O
incubate	incubate	VB	O
for	for	IN	O
1âh	1âh	CD	O
.	.	.	O

DNA	DNA	NNP	O
was	be	VBD	O
counterstained	counterstaine	VBN	O
with	with	IN	O
DAPI	dapi	NN	O
.	.	.	O

Coverslips	coverslip	NNS	O
were	be	VBD	O
mounted	mount	VBN	O
in	in	IN	O
ProLongTM	ProLongTM	NNP	O
Diamond	Diamond	NNP	O
Antifade	Antifade	NNP	O
Mountant	Mountant	NNP	O
.	.	.	O

ImageJ	ImageJ	NNP	O
was	be	VBD	O
used	use	VBN	O
to	to	TO	O
quantify	quantify	VB	O
the	the	DT	O
percentage	percentage	NN	O
of	of	IN	O
nuclei	nucleus	NNS	O
inside	inside	IN	O
the	the	DT	O
myotubes	myotube	NNS	O
compared	compare	VBN	O
to	to	IN	O
control	control	NN	O
.	.	.	O

Images	image	NNS	O
were	be	VBD	O
taken	take	VBN	O
with	with	IN	O
Nikon	Nikon	NNP	O
eclipse	eclipse	NN	O
TE300	TE300	NNP	O
microscope	microscope	NN	O
.	.	.	O

Pictures	picture	NNS	O
showed	show	VBD	O
in	in	IN	O
the	the	DT	O
figures	figure	NNS	O
are	be	VBP	O
representative	representative	JJ	O
of	of	IN	O
all	all	DT	O
examined	examine	VBN	O
fields	field	NNS	O
.	.	.	O

Total	total	JJ	O
DNA	DNA	NNP	O
was	be	VBD	O
isolated	isolate	VBN	O
using	use	VBG	O
phenol	phenol	NN	O
/	/	SYM	O
chloroform	chloroform	NN	O
-	-	HYPH	O
extraction	extraction	NN	O
.	.	.	O

mtDNA	mtDNA	NNP	O
was	be	VBD	O
quantified	quantify	VBN	O
by	by	IN	O
q	q	NNP	O
-	-	HYPH	O
PCR	PCR	NNP	O
using	use	VBG	O
PowerUpSYBR	powerupsybr	NN	O
Green	Green	NNP	O
PCR	PCR	NNP	O
Master	Master	NNP	O
mix	mix	NN	O
and	and	CC	O
analysed	analyse	VBD	O
on	on	IN	O
a	a	DT	O
StepOne	StepOne	NNP	O
Plus	Plus	NNP	O
Real	Real	NNP	O
-	-	HYPH	O
Time	time	NN	O
PCR	PCR	NNP	O
System	System	NNP	O
.	.	.	O

To	to	TO	O
evaluate	evaluate	VB	O
the	the	DT	O
amount	amount	NN	O
of	of	IN	O
mtDNA	mtdna	NN	O
present	present	NN	O
per	per	IN	O
nuclear	nuclear	JJ	O
genome	genome	NN	O
,	,	,	O
we	-PRON-	PRP	O
quantified	quantify	VBD	O
the	the	DT	O
relative	relative	JJ	O
copy	copy	NN	O
number	number	NN	O
differences	difference	NNS	O
through	through	IN	O
the	the	DT	O
ÎÎCt	îîct	NN	O
method	method	NN	B
,	,	,	O
comparing	compare	VBG	O
mtDNA	mtdna	NN	O
and	and	CC	O
nuclear	nuclear	JJ	O
DNA	dna	NN	O
using	use	VBG	O
the	the	DT	O
following	follow	VBG	O
primers	primer	NNS	O
sequences	sequence	NNS	O
:	:	:	O
mtDNA	mtDNA	NNP	O
CYTOCHROME	CYTOCHROME	NNP	O
C	C	NNP	O
FW	FW	NNP	O
:	:	:	O
5â²-TCATCCCTTGACATCGTGCT-3â	5â²-tcatcccttgacatcgtgct-3â	CD	O
RV	rv	NN	O
:	:	:	O
5â²-GTCTGAGTAGCGTCGTGGTA-3â	5â²-gtctgagtagcgtcgtggta-3â	CD	O
;	;	:	O
nuclear	nuclear	JJ	O
DNA	dna	NN	O
ACTIN	ACTIN	NNP	O
BETA	beta	NN	O
FW	fw	NN	O
:	:	:	O
5â²-CCCTGAGTGTTTCTTGTGGC-3â²	5â²-ccctgagtgtttcttgtggc-3â²	JJ	O
RV	rv	NN	O
:	:	:	O
5â²-GTCTCCGGAGTCCATCACAA-3â²	5â²-gtctccggagtccatcacaa-3â²	JJ	O
.	.	.	O

As	as	IN	O
a	a	DT	O
potent	potent	JJ	O
HMG	HMG	NNP	O
-	-	HYPH	O
CoA	CoA	NNP	O
inhibitor	inhibitor	NN	O
,	,	,	O
statins	statin	NNS	O
reduce	reduce	VBP	O
cellular	cellular	JJ	O
ergosterol	ergosterol	JJ	O
levels	level	NNS	O
also	also	RB	O
in	in	IN	O
S.	S.	NNP	O
cerevisiae	cerevisiae	NNS	O
.	.	.	O

Indeed	indeed	RB	O
,	,	,	O
the	the	DT	O
effect	effect	NN	O
of	of	IN	O
lovastatin	lovastatin	NN	O
on	on	IN	O
yeast	yeast	NN	O
was	be	VBD	O
previously	previously	RB	O
investigated	investigate	VBN	O
in	in	IN	O
the	the	DT	O
S.	S.	NNP	O
cerevisiae	cerevisiae	VBZ	O
wild	wild	JJ	O
type	type	NN	O
2180â1âA	2180â1âa	CD	B
,	,	,	B
and	and	CC	O
BY4741	BY4741	NNP	O
model	model	NN	O
laboratory	laboratory	NN	O
strains	strain	VBZ	B
.	.	.	O

Similarly	similarly	RB	O
,	,	,	O
the	the	DT	O
effect	effect	NN	O
of	of	IN	O
the	the	DT	O
additional	additional	JJ	O
statins	statin	NNS	O
,	,	,	O
including	include	VBG	O
rosuvastatin	rosuvastatin	NN	O
,	,	,	O
atorvastatin	atorvastatin	NNP	O
,	,	,	O
simvastatin	simvastatin	NNP	O
and	and	CC	O
fluvastatin	fluvastatin	NNP	O
was	be	VBD	O
tested	test	VBN	O
in	in	IN	O
the	the	DT	O
BY4742	BY4742	NNP	O
genotype	genotype	NN	O
,	,	,	O
expressing	express	VBG	O
the	the	DT	O
human	human	JJ	O
orthologue	orthologue	NN	O
of	of	IN	O
HMG	HMG	NNP	O
-	-	HYPH	O
CoA	CoA	NNP	B
.	.	.	O

Herein	Herein	NNP	O
,	,	,	O
we	-PRON-	PRP	O
used	use	VBD	O
S.	S.	NNP	O
cerevisiae	cerevisiae	VBZ	O
W303	w303	JJ	O
yeast	yeast	NN	O
cells	cell	NNS	O
to	to	TO	O
investigate	investigate	VB	O
the	the	DT	O
effects	effect	NNS	O
of	of	IN	O
human	human	JJ	O
HMG	HMG	NNP	O
-	-	HYPH	O
CoA	CoA	NNP	O
reductase	reductase	NN	O
inhibitors	inhibitor	NNS	O
;	;	:	O
W303	W303	NNP	O
is	be	VBZ	O
an	an	DT	O
excellent	excellent	JJ	O
model	model	NN	O
to	to	TO	O
study	study	VB	O
sterols	sterol	NNS	O
because	because	IN	O
the	the	DT	O
level	level	NN	O
of	of	IN	O
sterols	sterol	NNS	O
is	be	VBZ	O
higher	high	JJR	O
than	than	IN	O
in	in	IN	O
S288C	S288C	NNP	O
and	and	CC	O
derivative	derivative	JJ	O
strains	strain	NNS	B
,	,	,	B
.	.	.	O

To	to	TO	O
assess	assess	VB	O
the	the	DT	O
effect	effect	NN	O
of	of	IN	O
statins	statin	NNS	O
on	on	IN	O
mitochondria	mitochondria	NNP	O
,	,	,	O
we	-PRON-	PRP	O
selected	select	VBD	O
pravastatin	pravastatin	NNP	O
,	,	,	O
rosuvastatin	rosuvastatin	NNP	O
,	,	,	O
and	and	CC	O
atorvastatin	atorvastatin	VB	O
for	for	IN	O
our	-PRON-	PRP$	O
studies	study	NNS	O
,	,	,	O
at	at	IN	O
non	non	JJ	O
-	-	JJ	O
toxic	toxic	JJ	O
concentrations	concentration	NNS	O
previously	previously	RB	O
used	use	VBN	O
to	to	TO	O
study	study	VB	O
the	the	DT	O
effect	effect	NN	O
of	of	IN	O
statins	statin	NNS	O
on	on	IN	O
yeast	yeast	NN	B
.	.	.	O

The	the	DT	O
treatment	treatment	NN	O
of	of	IN	O
wild	wild	JJ	O
type	type	NN	O
W303	W303	NNP	O
cells	cell	NNS	O
with	with	IN	O
statins	statin	NNS	O
on	on	IN	O
agar	agar	NN	O
YPD	YPD	NNP	O
,	,	,	O
led	lead	VBD	O
to	to	IN	O
the	the	DT	O
production	production	NN	O
of	of	IN	O
high	high	JJ	O
percentage	percentage	NN	O
of	of	IN	O
small	small	JJ	O
colonies	colony	NNS	O
.	.	.	O

These	these	DT	O
colonies	colony	NNS	O
are	be	VBP	O
referred	refer	VBN	O
to	to	IN	O
as	as	IN	O
petites	petite	NNS	O
,	,	,	O
a	a	DT	O
phenotype	phenotype	NN	O
which	which	WDT	O
indicates	indicate	VBZ	O
a	a	DT	O
mitochondrial	mitochondrial	NN	O
dysfunction	dysfunction	NN	O
,	,	,	O
hence	hence	RB	O
we	-PRON-	PRP	O
assessed	assess	VBD	O
the	the	DT	O
effects	effect	NNS	O
of	of	IN	O
statins	statin	NNS	O
on	on	IN	O
yeast	yeast	NN	O
mitochondrial	mitochondrial	NN	O
function	function	NN	O
using	use	VBG	O
a	a	DT	O
petite	petite	JJ	O
assay	assay	NN	O
.	.	.	O

The	the	DT	O
petite	petite	JJ	O
phenotype	phenotype	NN	O
refers	refer	VBZ	O
to	to	IN	O
the	the	DT	O
size	size	NN	O
of	of	IN	O
a	a	DT	O
S.	S.	NNP	O
cerevisiae	cerevisiae	NN	O
colony	colony	NN	O
with	with	IN	O
rearrangements	rearrangement	NNS	O
rhoâ	rhoâ	NNP	O
or	or	CC	O
the	the	DT	O
lack	lack	NN	O
of	of	IN	O
mitochondrial	mitochondrial	NN	O
DNA	dna	NN	O
rhoÂ	rhoÂ	NNP	O
°	°	NNP	O
.	.	.	O

We	-PRON-	PRP	O
monitored	monitor	VBD	O
petite	petite	JJ	O
production	production	NN	O
plating	plate	VBG	O
the	the	DT	O
cultures	culture	NNS	O
at	at	IN	O
24	24	CD	O
,	,	,	O
48	48	CD	O
,	,	,	O
72âh	72âh	CD	O
of	of	IN	O
growth	growth	NN	O
.	.	.	O

At	at	IN	O
the	the	DT	O
concentration	concentration	NN	O
used	use	VBN	O
,	,	,	O
the	the	DT	O
statins	statin	NNS	O
induced	induce	VBD	O
a	a	DT	O
high	high	JJ	O
rate	rate	NN	O
of	of	IN	O
petite	petite	JJ	O
phenotype	phenotype	NN	O
,	,	,	O
especially	especially	RB	O
atorvastatin	atorvastatin	NN	O
and	and	CC	O
rosuvastatin	rosuvastatin	NN	O
Figure	figure	NN	O
1	1	CD	O
,	,	,	O
demonstrating	demonstrate	VBG	O
that	that	IN	O
the	the	DT	O
statins	statin	NNS	O
induced	induce	VBD	O
a	a	DT	O
defect	defect	NN	O
in	in	IN	O
mitochondrial	mitochondrial	NN	O
function	function	NN	O
,	,	,	O
similar	similar	JJ	O
to	to	IN	O
ketoconazole	ketoconazole	NNP	O
.	.	.	O

Statins	Statins	NNP	O
induced	induce	VBD	O
a	a	DT	O
high	high	JJ	O
percentage	percentage	NN	O
of	of	IN	O
petites	petite	NNS	O
production	production	NN	O
in	in	IN	O
yeast	yeast	NN	O
cells	cell	NNS	O
.	.	.	O

Percentage	percentage	NN	O
of	of	IN	O
petites	petite	NNS	O
production	production	NN	O
of	of	IN	O
wild	wild	JJ	O
type	type	NN	O
W303	W303	NNP	O
and	and	CC	O
W303	W303	NNP	O
rhoÂ	rhoÂ	NNS	O
°	°	NNS	O
grown	grow	VBN	O
in	in	IN	O
YPD	YPD	NNP	O
medium	medium	JJ	O
and	and	CC	O
wild	wild	JJ	O
type	type	NN	O
W303	W303	NNP	O
grown	grow	VBN	O
in	in	IN	O
YPD	YPD	NNP	O
medium	medium	NN	O
with	with	IN	O
pravastatin	pravastatin	NNP	O
150	150	CD	O
Âµg	Âµg	NNP	O
/	/	SYM	O
ml	ml	NNP	O
,	,	,	O
atorvastatin	atorvastatin	VB	O
100	100	CD	O
Âµg	Âµg	NNP	O
/	/	SYM	O
ml	ml	NNP	O
and	and	CC	O
rosuvastatin	rosuvastatin	NNP	O
50	50	CD	O
Âµg	Âµg	NNP	O
/	/	SYM	O
ml	ml	NNP	O
.	.	.	O

The	the	DT	O
petite	petite	JJ	O
phenotype	phenotype	NN	O
is	be	VBZ	O
suppressed	suppress	VBN	O
by	by	IN	O
ergosterol	ergosterol	NN	O
.	.	.	O

The	the	DT	O
same	same	JJ	O
statins	statin	NNS	O
treatments	treatment	NNS	O
as	as	IN	O
in	in	IN	O
didnât	didnât	:	O
show	show	VB	O
a	a	DT	O
petite	petite	JJ	O
phenotype	phenotype	NN	O
production	production	NN	O
in	in	IN	O
cells	cell	NNS	O
grown	grow	VBN	O
in	in	IN	O
a	a	DT	O
medium	medium	NN	O
supplemented	supplement	VBN	O
with	with	IN	O
ergosterol	ergosterol	NN	O
.	.	.	O

Cultures	culture	NNS	O
grown	grow	VBD	O
24	24	CD	O
,	,	,	O
48	48	CD	O
and	and	CC	O
72	72	CD	O
hours	hour	NNS	O
were	be	VBD	O
plated	plate	VBN	O
on	on	IN	O
YPD	YPD	NNP	O
plates	plate	NNS	O
and	and	CC	O
petites	petite	NNS	O
were	be	VBD	O
counted	count	VBN	O
after	after	IN	O
a	a	DT	O
replica	replica	NN	O
plating	plate	VBG	O
on	on	IN	O
glycerol	glycerol	NN	O
containing	contain	VBG	O
medium	medium	NN	O
.	.	.	O

Data	datum	NNS	O
are	be	VBP	O
the	the	DT	O
average	average	NN	O
of	of	IN	O
3	3	CD	O
independent	independent	JJ	O
experiments	experiment	NNS	O
and	and	CC	O
standard	standard	JJ	O
deviation	deviation	NN	O
is	be	VBZ	O
indicated	indicate	VBN	O
.	.	.	O

The	the	DT	O
asterisks	asterisk	NNS	O
indicate	indicate	VBP	O
significant	significant	JJ	O
modulations	modulation	NNS	O
according	accord	VBG	O
to	to	IN	O
Studentâs	studentâs	CD	O
T	t	NN	O
-	-	HYPH	O
test	test	NN	O
.	.	.	O

We	-PRON-	PRP	O
previously	previously	RB	O
show	show	VBP	O
that	that	IN	O
in	in	IN	O
yeast	yeast	NN	O
,	,	,	O
the	the	DT	O
presence	presence	NN	O
of	of	IN	O
ergosterol	ergosterol	NN	O
0.5âmg	0.5âmg	NNS	O
/	/	SYM	O
ml	ml	NNP	O
in	in	IN	O
growth	growth	NN	O
medium	medium	NN	O
suppressed	suppress	VBD	O
the	the	DT	O
petite	petite	JJ	O
phenotype	phenotype	NN	O
induced	induce	VBN	O
by	by	IN	O
ketoconazole	ketoconazole	JJ	B
.	.	.	O

We	-PRON-	PRP	O
verified	verify	VBD	O
if	if	IN	O
the	the	DT	O
generation	generation	NN	O
of	of	IN	O
petite	petite	JJ	O
colonies	colony	NNS	O
in	in	IN	O
presence	presence	NN	O
of	of	IN	O
statins	statin	NNS	O
could	could	MD	O
be	be	VB	O
counteracted	counteract	VBN	O
by	by	IN	O
adding	add	VBG	O
ergosterol	ergosterol	RB	O
,	,	,	O
at	at	IN	O
a	a	DT	O
concentration	concentration	NN	O
used	use	VBN	O
to	to	TO	O
suppress	suppress	VB	O
the	the	DT	O
ketoconazole	ketoconazole	JJ	O
effects	effect	NNS	O
.	.	.	O

Indeed	indeed	RB	O
,	,	,	O
the	the	DT	O
percentage	percentage	NN	O
of	of	IN	O
petite	petite	NN	O
was	be	VBD	O
very	very	RB	O
low	low	JJ	O
in	in	IN	O
presence	presence	NN	O
of	of	IN	O
ergosterol	ergosterol	NN	O
,	,	,	O
in	in	IN	O
similar	similar	JJ	O
to	to	IN	O
the	the	DT	O
wild	wild	JJ	O
type	type	NN	O
strain	strain	NN	O
with	with	IN	O
functional	functional	JJ	O
mitochondria	mitochondrion	NNS	O
Figure	Figure	NNP	O
1	1	CD	O
.	.	.	O

Because	because	IN	O
treated	treat	VBN	O
cells	cell	NNS	O
showed	show	VBD	O
different	different	JJ	O
size	size	NN	O
,	,	,	O
we	-PRON-	PRP	O
verified	verify	VBD	O
cellular	cellular	JJ	O
vitality	vitality	NN	O
by	by	IN	O
counting	count	VBG	O
cells	cell	NNS	O
number	number	NN	O
to	to	TO	O
construct	construct	VB	O
growth	growth	NN	O
curves	curve	NNS	O
,	,	,	O
which	which	WDT	O
is	be	VBZ	O
not	not	RB	O
consider	consider	VB	O
with	with	IN	O
optical	optical	JJ	O
density	density	NN	O
measure	measure	NN	O
Supplementary	Supplementary	NNP	O
Figure	Figure	NNP	O
3	3	CD	O
.	.	.	O

Of	of	IN	O
note	note	NN	O
,	,	,	O
treatments	treatment	NNS	O
of	of	IN	O
W303	W303	NNP	O
with	with	IN	O
statins	statin	NNS	O
resulted	result	VBN	O
in	in	IN	O
intermediate	intermediate	JJ	O
growth	growth	NN	O
curves	curve	NNS	O
,	,	,	O
located	locate	VBN	O
between	between	IN	O
the	the	DT	O
non	non	JJ	O
-	-	JJ	O
treated	treat	VBN	O
W303	W303	NNP	O
strain	strain	NN	O
and	and	CC	O
the	the	DT	O
strain	strain	NN	O
devoid	devoid	NN	O
of	of	IN	O
mitochondrial	mitochondrial	NN	O
DNA	dna	NN	O
W303	W303	NNP	O
rhoÂ	rhoÂ	NNS	O
°	°	NNS	O
,	,	,	O
while	while	IN	O
the	the	DT	O
presence	presence	NN	O
of	of	IN	O
ergosterol	ergosterol	NN	O
in	in	IN	O
the	the	DT	O
medium	medium	NN	O
restores	restore	VBZ	O
a	a	DT	O
wild	wild	JJ	O
type	type	NN	O
growth	growth	NN	O
in	in	IN	O
statin	statin	NN	O
treated	treat	VBN	O
cells	cell	NNS	O
and	and	CC	O
in	in	IN	O
W303	w303	JJ	O
rhoÂ	rhoÂ	NNS	O
°	°	NNS	O
Supplementary	Supplementary	NNP	O
Figure	Figure	NNP	O
3	3	CD	O
.	.	.	O

These	these	DT	O
results	result	NNS	O
suggest	suggest	VBP	O
that	that	IN	O
statins	statin	VBZ	O
treatment	treatment	NN	O
induced	induce	VBN	O
mitochondrial	mitochondrial	NN	O
dysfunction	dysfunction	NN	O
in	in	IN	O
S.	S.	NNP	O
cerevisiae	cerevisiae	NNS	O
by	by	IN	O
lowering	lower	VBG	O
ergosterol	ergosterol	JJ	O
content	content	NN	O
.	.	.	O

To	to	TO	O
verify	verify	VB	O
this	this	DT	O
hypothesis	hypothesis	NN	O
,	,	,	O
we	-PRON-	PRP	O
measured	measure	VBD	O
the	the	DT	O
content	content	NN	O
of	of	IN	O
ergosterol	ergosterol	NN	O
in	in	IN	O
W303	w303	CD	O
wild	wild	JJ	O
type	type	NN	O
cells	cell	NNS	O
treated	treat	VBN	O
with	with	IN	O
statins	statin	NNS	O
,	,	,	O
using	use	VBG	O
,	,	,	O
as	as	IN	O
a	a	DT	O
control	control	NN	O
,	,	,	O
W303	W303	NNP	O
rhoÂ	rhoÂ	NNS	O
°	°	NNS	O
strain	strain	NN	O
,	,	,	O
which	which	WDT	O
has	have	VBZ	O
a	a	DT	O
low	low	JJ	O
ergosterol	ergosterol	JJ	O
content	content	NN	B
.	.	.	O

Ergosterol	ergosterol	JJ	O
content	content	NN	O
was	be	VBD	O
measured	measure	VBN	O
in	in	IN	O
yeast	yeast	NN	O
cells	cell	NNS	O
treated	treat	VBN	O
with	with	IN	O
statins	statin	NNS	O
by	by	IN	O
gas	gas	NN	O
chromatography	chromatography	NN	O
-	-	HYPH	O
mass	mass	NN	O
spectrometry	spectrometry	NN	O
.	.	.	O

The	the	DT	O
results	result	NNS	O
revealed	reveal	VBD	O
that	that	IN	O
ergosterol	ergosterol	JJ	O
content	content	NN	O
was	be	VBD	O
significantly	significantly	RB	O
lower	low	JJR	O
in	in	IN	O
statin	statin	NN	O
-	-	HYPH	O
treated	treat	VBN	O
cells	cell	NNS	O
,	,	,	O
compared	compare	VBN	O
with	with	IN	O
the	the	DT	O
non	non	JJ	O
-	-	JJ	O
treated	treated	JJ	O
wild	wild	JJ	O
type	type	NN	O
strain	strain	NN	O
.	.	.	O

These	these	DT	O
results	result	NNS	O
are	be	VBP	O
in	in	IN	O
agreement	agreement	NN	O
with	with	IN	O
a	a	DT	O
previous	previous	JJ	O
study	study	NN	O
in	in	IN	O
Candida	Candida	NNP	O
glabrata	glabrata	NN	O
,	,	,	O
demonstrates	demonstrate	VBZ	O
that	that	IN	O
simvastatin	simvastatin	NN	O
reduces	reduce	NNS	O
ergosterol	ergosterol	VBP	O
quantities	quantity	NNS	O
in	in	IN	O
cells	cell	NNS	B
.	.	.	O

To	to	TO	O
establish	establish	VB	O
if	if	IN	O
statins	statins	NNP	O
act	act	VBP	O
directly	directly	RB	O
on	on	IN	O
the	the	DT	O
stability	stability	NN	O
of	of	IN	O
mitochondrial	mitochondrial	NN	O
DNA	dna	NN	O
,	,	,	O
because	because	IN	O
of	of	IN	O
low	low	JJ	O
ergosterol	ergosterol	JJ	O
content	content	NN	O
,	,	,	O
we	-PRON-	PRP	O
visualised	visualise	VBD	O
mitochondrial	mitochondrial	NN	O
DNA	dna	NN	O
from	from	IN	O
petite	petite	JJ	O
colonies	colony	NNS	O
by	by	IN	O
DAPI	dapi	NN	O
staining	staining	NN	O
.	.	.	O

Results	result	NNS	O
,	,	,	O
reported	report	VBN	O
in	in	IN	O
Figure	Figure	NNP	O
2	2	CD	O
,	,	,	O
showed	show	VBD	O
that	that	IN	O
wild	wild	JJ	O
type	type	NN	O
cells	cell	NNS	O
contained	contain	VBD	O
mitochondrial	mitochondrial	NN	O
DNA	dna	NN	O
,	,	,	O
W303	W303	NNP	O
rhoÂ	rhoÂ	NNS	O
°	°	NNS	O
cells	cell	NNS	O
had	have	VBD	O
only	only	RB	O
nuclear	nuclear	JJ	O
DNA	dna	NN	O
and	and	CC	O
wild	wild	JJ	O
type	type	NN	O
cells	cell	NNS	O
treated	treat	VBN	O
with	with	IN	O
statins	statin	NNS	O
showed	show	VBD	O
a	a	DT	O
high	high	JJ	O
percentage	percentage	NN	O
of	of	IN	O
cells	cell	NNS	O
devoid	devoid	JJ	O
of	of	IN	O
mitochondrial	mitochondrial	NN	O
DNA	dna	NN	O
.	.	.	O

The	the	DT	O
quantitative	quantitative	JJ	O
analysis	analysis	NN	O
of	of	IN	O
rhoÂ	rhoÂ	NNS	O
°	°	NNS	O
cells	cell	NNS	O
generated	generate	VBN	O
by	by	IN	O
statins	statin	NNS	O
is	be	VBZ	O
reported	report	VBN	O
in	in	IN	O
Figure	figure	NN	O
2	2	CD	O
:	:	:	O
histograms	histogram	NNS	O
report	report	VBP	O
the	the	DT	O
percentage	percentage	NN	O
of	of	IN	O
cells	cell	NNS	O
without	without	IN	O
mitochondrial	mitochondrial	NN	O
DNA	dna	NN	O
.	.	.	O

The	the	DT	O
same	same	JJ	O
experiment	experiment	NN	O
was	be	VBD	O
performed	perform	VBN	O
in	in	IN	O
parallel	parallel	NN	O
with	with	IN	O
cultures	culture	NNS	O
grown	grow	VBN	O
in	in	IN	O
YPDE	YPDE	NNP	O
medium	medium	NN	O
.	.	.	O

Statins	Statins	NNP	O
treatments	treatment	NNS	O
induced	induce	VBD	O
the	the	DT	O
loss	loss	NN	O
of	of	IN	O
mitochondrial	mitochondrial	NN	O
DNA	dna	NN	O
and	and	CC	O
the	the	DT	O
ergosterol	ergosterol	NN	O
suppressed	suppress	VBD	O
this	this	DT	O
phenotype	phenotype	NN	O
.	.	.	O

DAPI	dapi	NN	O
staining	staining	NN	O
of	of	IN	O
cells	cell	NNS	O
presented	present	VBN	O
in	in	IN	O
Fig	Fig	NNP	O
.	.	NNP	O

1	1	CD	O
;	;	:	O
wild	wild	JJ	O
type	type	NN	O
W303	W303	NNP	O
,	,	,	O
W303	W303	NNP	O
rhoÂ	rhoÂ	NNS	O
°	°	NNS	O
and	and	CC	O
wild	wild	JJ	O
type	type	NN	O
W303	W303	NNP	O
treated	treat	VBN	O
with	with	IN	O
pravastatin	pravastatin	NNP	O
150	150	CD	O
Âµg	Âµg	NNP	O
/	/	SYM	O
ml	ml	NNP	O
,	,	,	O
atorvastatin	atorvastatin	VB	O
100	100	CD	O
Âµg	Âµg	NNP	O
/	/	SYM	O
ml	ml	NNP	O
and	and	CC	O
rosuvastatin	rosuvastatin	NNP	O
50	50	CD	O
Âµg	Âµg	NNP	O
/	/	SYM	O
ml	ml	NNP	O
grown	grow	VBN	O
in	in	IN	O
YPD	YPD	NNP	O
and	and	CC	O
YPDE	YPDE	NNP	O
media	medium	NNS	O
.	.	.	O

Bar	bar	NN	O
:	:	:	O
2	2	CD	O
Âµm	Âµm	NNP	O
.	.	.	O

The	the	DT	O
magnification	magnification	NN	O
is	be	VBZ	O
the	the	DT	O
same	same	JJ	O
in	in	IN	O
each	each	DT	O
picture	picture	NN	O
.	.	.	O

The	the	DT	O
histogram	histogram	NN	O
shows	show	VBZ	O
the	the	DT	O
percentage	percentage	NN	O
of	of	IN	O
cells	cell	NNS	O
without	without	IN	O
mitochondrial	mitochondrial	NN	O
DNA	dna	NN	O
.	.	.	O

An	an	DT	O
average	average	NN	O
of	of	IN	O
300	300	CD	O
cells	cell	NNS	O
were	be	VBD	O
counted	count	VBN	O
.	.	.	O

Results	result	NNS	O
demonstrated	demonstrate	VBD	O
that	that	IN	O
statins	statin	NNS	O
induced	induce	VBD	O
the	the	DT	O
loss	loss	NN	O
of	of	IN	O
mitochondrial	mitochondrial	NN	O
DNA	dna	NN	O
and	and	CC	O
that	that	IN	O
the	the	DT	O
presence	presence	NN	O
of	of	IN	O
ergosterol	ergosterol	NN	O
suppressed	suppress	VBD	O
this	this	DT	O
phenotype	phenotype	NN	O
;	;	:	O
we	-PRON-	PRP	O
also	also	RB	O
verified	verify	VBD	O
that	that	IN	O
the	the	DT	O
colonies	colony	NNS	O
with	with	IN	O
mitochondrial	mitochondrial	NN	O
DNA	DNA	NNP	O
were	be	VBD	O
able	able	JJ	O
to	to	TO	O
grow	grow	VB	O
on	on	IN	O
glycerol	glycerol	JJ	O
medium	medium	NN	O
.	.	.	O

This	this	DT	O
result	result	NN	O
indicate	indicate	VBP	O
that	that	DT	O
loss	loss	NN	O
of	of	IN	O
mitochondrial	mitochondrial	NN	O
DNA	dna	NN	O
was	be	VBD	O
correlated	correlate	VBN	O
to	to	IN	O
low	low	JJ	O
concentration	concentration	NN	O
of	of	IN	O
ergosterol	ergosterol	NN	O
in	in	IN	O
the	the	DT	O
mitochondrial	mitochondrial	NN	O
membranes	membrane	NNS	O
and	and	CC	O
that	that	IN	O
the	the	DT	O
exogenous	exogenous	JJ	O
addition	addition	NN	O
of	of	IN	O
ergosterol	ergosterol	NN	O
was	be	VBD	O
sufficient	sufficient	JJ	O
to	to	TO	O
stabilise	stabilise	VB	O
the	the	DT	O
mitochondrial	mitochondrial	NN	O
DNA	dna	NN	O
,	,	,	O
counteracting	counteract	VBG	O
the	the	DT	O
statins	statin	NNS	O
effect	effect	NN	O
.	.	.	O

We	-PRON-	PRP	O
then	then	RB	O
measured	measure	VBD	O
the	the	DT	O
oxygen	oxygen	NN	O
consumption	consumption	NN	O
of	of	IN	O
cells	cell	NNS	O
treated	treat	VBN	O
with	with	IN	O
statins	statin	NNS	O
;	;	:	O
Figure	Figure	NNP	O
3reports	3reports	NNP	O
that	that	IN	O
the	the	DT	O
respiration	respiration	NN	O
rate	rate	NN	O
of	of	IN	O
wild	wild	JJ	O
type	type	NN	O
strain	strain	NN	O
treated	treat	VBN	O
with	with	IN	O
statins	statin	NNS	O
is	be	VBZ	O
lower	low	JJR	O
if	if	IN	O
compared	compare	VBN	O
with	with	IN	O
the	the	DT	O
non	non	JJ	O
-	-	JJ	O
treated	treated	JJ	O
wild	wild	JJ	O
type	type	NN	O
cells	cell	NNS	O
;	;	:	O
when	when	WRB	O
the	the	DT	O
same	same	JJ	O
cultures	culture	NNS	O
were	be	VBD	O
grown	grow	VBN	O
in	in	IN	O
YPD	YPD	NNP	O
medium	medium	NN	O
supplemented	supplement	VBN	O
with	with	IN	O
ergosterol	ergosterol	NN	O
,	,	,	O
the	the	DT	O
respiration	respiration	NN	O
rate	rate	NN	O
was	be	VBD	O
higher	high	JJR	O
,	,	,	O
indicating	indicate	VBG	O
that	that	IN	O
the	the	DT	O
presence	presence	NN	O
of	of	IN	O
ergosterol	ergosterol	JJ	O
compensate	compensate	NN	O
for	for	IN	O
the	the	DT	O
effect	effect	NN	O
of	of	IN	O
statins	statin	NNS	O
Figure	figure	NN	O
3	3	CD	O
.	.	.	O

This	this	DT	O
result	result	NN	O
suggests	suggest	VBZ	O
an	an	DT	O
impairment	impairment	NN	O
of	of	IN	O
the	the	DT	O
respiratory	respiratory	JJ	O
chain	chain	NN	O
function	function	NN	O
when	when	WRB	O
cells	cell	NNS	O
were	be	VBD	O
treated	treat	VBN	O
with	with	IN	O
statins	statin	NNS	O
.	.	.	O

The	the	DT	O
oxygen	oxygen	NN	O
consumption	consumption	NN	O
rate	rate	NN	O
of	of	IN	O
yeast	yeast	NN	O
cells	cell	NNS	O
treated	treat	VBN	O
with	with	IN	O
statins	statin	NNS	O
is	be	VBZ	O
low	low	RB	O
compared	compare	VBN	O
to	to	IN	O
the	the	DT	O
wild	wild	JJ	O
type	type	NN	O
strain	strain	NN	O
.	.	.	O

Oxygen	oxygen	NN	O
consumption	consumption	NN	O
of	of	IN	O
W303	W303	NNP	O
,	,	,	O
W303	W303	NNP	O
rhoÂ	rhoÂ	NNS	O
°	°	NNS	O
and	and	CC	O
W303	w303	JJ	O
cells	cell	NNS	O
treated	treat	VBN	O
with	with	IN	O
statins	statin	NNS	O
in	in	IN	O
YPD	YPD	NNP	O
medium	medium	NN	O
showed	show	VBD	O
low	low	JJ	O
oxygen	oxygen	NN	O
consumption	consumption	NN	O
in	in	IN	O
cells	cell	NNS	O
treated	treat	VBN	O
with	with	IN	O
statins	statin	NNS	O
;	;	:	O
The	the	DT	O
respiration	respiration	NN	O
rate	rate	NN	O
is	be	VBZ	O
higher	high	JJR	O
when	when	WRB	O
the	the	DT	O
same	same	JJ	O
cultures	culture	NNS	O
were	be	VBD	O
grown	grow	VBN	O
in	in	IN	O
YPD	YPD	NNP	O
medium	medium	NN	O
supplemented	supplement	VBN	O
with	with	IN	O
ergosterol	ergosterol	NN	O
.	.	.	O

The	the	DT	O
oxygen	oxygen	NN	O
consumption	consumption	NN	O
rate	rate	NN	O
is	be	VBZ	O
expressed	express	VBN	O
as	as	IN	O
O2	O2	NNP	O
nmol	nmol	NNP	O
/	/	SYM	O
ml	ml	NNP	O
,	,	,	O
and	and	CC	O
the	the	DT	O
respiration	respiration	NN	O
rates	rate	NNS	O
was	be	VBD	O
normalized	normalize	VBN	O
for	for	IN	O
cell	cell	NN	O
number	number	NN	O
.	.	.	O

In	in	IN	O
yeast	yeast	NN	O
,	,	,	O
cells	cell	NNS	O
lacking	lack	VBG	O
mitochondrial	mitochondrial	NN	O
DNA	dna	NN	O
or	or	CC	O
a	a	DT	O
conditional	conditional	JJ	O
mutant	mutant	NN	O
of	of	IN	O
the	the	DT	O
ergosterol	ergosterol	JJ	O
pathway	pathway	JJ	O
show	show	NN	O
defects	defect	NNS	O
in	in	IN	O
mitochondrial	mitochondrial	NN	O
morphology	morphology	NN	B
and	and	CC	O
a	a	DT	O
down	down	JJ	O
regulation	regulation	NN	O
of	of	IN	O
the	the	DT	O
ergosterol	ergosterol	JJ	O
genes	gene	NNS	O
results	result	NNS	O
in	in	IN	O
mitochondrial	mitochondrial	NN	O
membrane	membrane	NN	O
alteration	alteration	NN	B
,	,	,	B
.	.	.	O

We	-PRON-	PRP	O
therefore	therefore	RB	O
analysed	analyse	VBD	O
mitochondrial	mitochondrial	NN	O
morphology	morphology	NN	O
after	after	IN	O
statins	statin	NNS	O
treatment	treatment	NN	O
Figure	figure	NN	O
4	4	CD	O
.	.	.	O

Accordingly	accordingly	RB	O
,	,	,	O
wild	wild	JJ	O
type	type	NN	O
strain	strain	NN	O
transformed	transform	VBN	O
with	with	IN	O
a	a	DT	O
vector	vector	NN	O
expressing	express	VBG	O
the	the	DT	O
mitoGFP	mitoGFP	NNP	O
for	for	IN	O
green	green	JJ	O
fluorescent	fluorescent	JJ	O
labelling	labelling	NN	O
of	of	IN	O
mitochondria	mitochondria	NNP	O
in	in	IN	O
living	live	VBG	O
cells	cell	NNS	O
,	,	,	O
and	and	CC	O
mitochondrial	mitochondrial	NN	O
morphology	morphology	NN	O
was	be	VBD	O
assessed	assess	VBN	O
upon	upon	IN	O
treatment	treatment	NN	O
with	with	IN	O
statins	statin	NNS	O
at	at	IN	O
exponential	exponential	JJ	O
phase	phase	NN	O
,	,	,	O
in	in	IN	O
glucose	glucose	NN	O
-	-	HYPH	O
containing	contain	VBG	O
medium	medium	NN	O
with	with	IN	O
or	or	CC	O
without	without	IN	O
ergosterol	ergosterol	NN	O
.	.	.	O

By	by	IN	O
fluorescence	fluorescence	NN	O
microscopy	microscopy	NN	O
,	,	,	O
we	-PRON-	PRP	O
observed	observe	VBD	O
a	a	DT	O
relevant	relevant	JJ	O
percentage	percentage	NN	O
of	of	IN	O
aggregated	aggregate	VBN	O
vs	vs	IN	O
tubular	tubular	JJ	O
mitochondria	mitochondrion	NNS	O
in	in	IN	O
wild	wild	JJ	O
type	type	NN	O
strain	strain	NN	O
treated	treat	VBN	O
with	with	IN	O
statins	statin	NNS	O
.	.	.	O

This	this	DT	O
phenotype	phenotype	NN	O
is	be	VBZ	O
reminiscent	reminiscent	JJ	O
of	of	IN	O
mutants	mutant	NNS	O
lacking	lack	VBG	O
mitochondrial	mitochondrial	NN	O
DNA	dna	NN	O
,	,	,	O
or	or	CC	O
of	of	IN	O
W303	w303	JJ	O
rhoÂ	rhoÂ	NNS	O
°	°	NNS	O
strain	strain	VBP	B
.	.	.	O

The	the	DT	O
addition	addition	NN	O
of	of	IN	O
ergosterol	ergosterol	NN	O
partially	partially	RB	O
suppressed	suppress	VBD	O
the	the	DT	O
aggregated	aggregated	JJ	O
mitochondrial	mitochondrial	NN	O
morphology	morphology	NN	O
phenotype	phenotype	NN	O
,	,	,	O
partially	partially	RB	O
restoring	restore	VBG	O
a	a	DT	O
tubular	tubular	JJ	O
mitochondrial	mitochondrial	NN	O
structure	structure	NN	O
Figure	figure	NN	O
4	4	CD	O
.	.	.	O

By	by	IN	O
staining	stain	VBG	O
cells	cell	NNS	O
with	with	IN	O
DAPI	dapi	NN	O
,	,	,	O
we	-PRON-	PRP	O
were	be	VBD	O
able	able	JJ	O
to	to	TO	O
verify	verify	VB	O
the	the	DT	O
presence	presence	NN	O
of	of	IN	O
mitochondrial	mitochondrial	NN	O
DNA	dna	NN	O
in	in	IN	O
the	the	DT	O
strains	strain	NNS	O
expressing	express	VBG	O
mitoGFP	mitoGFP	NNP	O
,	,	,	O
treated	treat	VBN	O
with	with	IN	O
statins	statin	NNS	O
,	,	,	O
and	and	CC	O
supplemented	supplement	VBN	O
with	with	IN	O
ergosterol	ergosterol	NN	O
.	.	.	O

Statins	Statins	NNP	O
treatments	treatment	NNS	O
in	in	IN	O
S.	S.	NNP	O
cerevisiae	cerevisiae	NNS	O
results	result	NNS	O
in	in	IN	O
an	an	DT	O
aberrant	aberrant	JJ	O
mitochondrial	mitochondrial	NN	O
morphology	morphology	NN	O
phenotype	phenotype	NN	O
,	,	,	O
similar	similar	JJ	O
to	to	IN	O
that	that	DT	O
of	of	IN	O
rhoÂ	rhoÂ	NNS	O
°	°	NNS	O
cells	cell	NNS	O
and	and	CC	O
this	this	DT	O
phenotype	phenotype	NN	O
is	be	VBZ	O
suppressed	suppress	VBN	O
by	by	IN	O
ergosterol	ergosterol	NN	O
.	.	.	O

W303	W303	NNP	O
was	be	VBD	O
treated	treat	VBN	O
with	with	IN	O
pravastatin	pravastatin	NNP	O
150	150	CD	O
Âµg	Âµg	NNP	O
/	/	SYM	O
ml	ml	NNP	O
,	,	,	O
atorvastatin	atorvastatin	VB	O
100Âµg	100âµg	CD	O
/	/	SYM	O
ml	ml	NN	O
and	and	CC	O
rosuvastatin	rosuvastatin	NNP	O
50	50	CD	O
Âµg	Âµg	NNP	O
/	/	SYM	O
ml	ml	NNP	O
grown	grow	VBN	O
in	in	IN	O
YPD	YPD	NNP	O
and	and	CC	O
YPDE	YPDE	NNP	O
media	medium	NNS	O
in	in	IN	O
exponential	exponential	JJ	O
growth	growth	NN	O
phase	phase	NN	O
;	;	:	O
mitochondria	mitochondria	NNP	O
were	be	VBD	O
visualized	visualize	VBN	O
with	with	IN	O
mitoGFP	mitoGFP	NNP	O
.	.	.	O

The	the	DT	O
histogram	histogram	NN	O
shows	show	VBZ	O
the	the	DT	O
percentage	percentage	NN	O
of	of	IN	O
cells	cell	NNS	O
with	with	IN	O
tubular	tubular	JJ	O
mitochondria	mitochondrion	NNS	O
.	.	.	O

As	as	IN	O
a	a	DT	O
control	control	NN	O
,	,	,	O
W303	W303	NNP	O
rhoÂ	rhoÂ	NNS	O
°	°	NNS	O
strain	strain	NN	O
was	be	VBD	O
used	use	VBN	O
.	.	.	O

Bar	bar	NN	O
:	:	:	O
2	2	CD	O
Âµm	Âµm	NNP	O
.	.	.	O

The	the	DT	O
magnification	magnification	NN	O
is	be	VBZ	O
the	the	DT	O
same	same	JJ	O
in	in	IN	O
each	each	DT	O
picture	picture	NN	O
.	.	.	O

Erg27	Erg27	NNP	O
is	be	VBZ	O
an	an	DT	O
essential	essential	JJ	O
enzyme	enzyme	NNS	O
of	of	IN	O
the	the	DT	O
ergosterol	ergosterol	JJ	O
biosynthetic	biosynthetic	JJ	O
pathway	pathway	NN	O
that	that	WDT	O
plays	play	VBZ	O
as	as	IN	O
a	a	DT	O
sensor	sensor	NN	O
of	of	IN	O
mitochondrial	mitochondrial	NN	O
function	function	NN	O
:	:	:	O
in	in	IN	O
wild	wild	JJ	O
type	type	NN	O
cells	cell	NNS	O
the	the	DT	O
enzyme	enzyme	NNS	O
is	be	VBZ	O
mainly	mainly	RB	O
found	find	VBN	O
in	in	IN	O
Lipid	Lipid	NNP	O
Droplets	Droplets	NNPS	O
,	,	,	O
while	while	IN	O
in	in	IN	O
cells	cell	NNS	O
with	with	IN	O
a	a	DT	O
block	block	NN	O
of	of	IN	O
respiration	respiration	NN	O
or	or	CC	O
in	in	IN	O
rhoÂ	rhoÂ	NNS	O
°	°	NNS	O
cells	cell	NNS	O
,	,	,	O
it	-PRON-	PRP	O
moves	move	VBZ	O
to	to	IN	O
the	the	DT	O
nuclear	nuclear	JJ	O
and	and	CC	O
cortical	cortical	JJ	O
Endoplasmic	Endoplasmic	NNP	O
Reticulum	Reticulum	NNP	B
.	.	.	O

To	to	TO	O
assess	assess	VB	O
a	a	DT	O
possible	possible	JJ	O
mitochondrial	mitochondrial	NN	O
defect	defect	NN	O
,	,	,	O
we	-PRON-	PRP	O
determined	determine	VBD	O
the	the	DT	O
cellular	cellular	JJ	O
localisation	localisation	NN	O
of	of	IN	O
Erg27	Erg27	NNP	O
following	follow	VBG	O
statins	statin	NNS	O
treatment	treatment	NN	O
.	.	.	O

Wild	wild	JJ	O
type	type	NN	O
W303	W303	NNP	O
and	and	CC	O
W303	W303	NNP	O
rhoÂ	rhoÂ	NNS	O
°	°	NNS	O
strains	strain	NNS	O
,	,	,	O
harbouring	harbour	VBG	O
the	the	DT	O
ERG27-GFP	ERG27-GFP	NNP	O
fusion	fusion	NN	O
integrated	integrate	VBN	O
in	in	IN	O
the	the	DT	O
genome	genome	NN	O
,	,	,	O
were	be	VBD	O
treated	treat	VBN	O
with	with	IN	O
statins	statin	NNS	O
and	and	CC	O
analysed	analyse	VBN	O
by	by	IN	O
fluorescence	fluorescence	NN	O
microscopy	microscopy	NN	O
.	.	.	O

Results	result	NNS	O
reported	report	VBD	O
in	in	IN	O
Figure	Figure	NNP	O
5	5	CD	O
showed	show	VBD	O
that	that	IN	O
in	in	IN	O
wild	wild	JJ	O
type	type	NN	O
cells	cell	NNS	O
,	,	,	O
Erg27-GFP	Erg27-GFP	NNP	O
decorated	decorate	VBD	O
lipid	lipid	NN	O
droplets	droplet	NNS	O
,	,	,	O
while	while	IN	O
in	in	IN	O
cells	cell	NNS	O
treated	treat	VBN	O
with	with	IN	O
statins	statin	NNS	O
,	,	,	O
Erg27-GFP	Erg27-GFP	NNP	O
re	re	NNS	O
-	-	VBN	O
localised	localise	VBN	O
in	in	IN	O
nuclear	nuclear	JJ	O
and	and	CC	O
cortical	cortical	JJ	O
ER	ER	NNP	O
,	,	,	O
as	as	IN	O
in	in	IN	O
W303	W303	NNP	O
rhoÂ	rhoÂ	NNS	O
°	°	NNS	O
cells	cell	NNS	O
.	.	.	O

The	the	DT	O
re	re	NN	O
-	-	NN	O
localisation	localisation	NN	O
of	of	IN	O
Erg27-GFP	Erg27-GFP	NNP	O
demonstrated	demonstrate	VBD	O
that	that	IN	O
statins	statin	NNS	O
,	,	,	O
similarly	similarly	RB	O
to	to	IN	O
a	a	DT	O
block	block	NN	O
of	of	IN	O
respiration	respiration	NN	O
,	,	,	O
induced	induce	VBD	O
the	the	DT	O
movement	movement	NN	O
of	of	IN	O
Erg27	Erg27	NNP	O
from	from	IN	O
lipid	lipid	NN	O
droplets	droplet	NNS	O
to	to	IN	O
the	the	DT	O
endoplasmic	endoplasmic	JJ	O
reticulum	reticulum	NN	O
.	.	.	O

Statins	Statins	NNP	O
treatments	treatment	NNS	O
induced	induce	VBD	O
the	the	DT	O
re	re	NN	O
-	-	NN	O
localization	localization	NN	O
of	of	IN	O
Erg27	Erg27	NNP	O
,	,	,	O
a	a	DT	O
sensor	sensor	NN	O
of	of	IN	O
mitochondrial	mitochondrial	NN	O
state	state	NN	O
,	,	,	O
from	from	IN	O
lipid	lipid	NN	O
droplets	droplet	NNS	O
to	to	IN	O
nuclear	nuclear	JJ	O
and	and	CC	O
cortical	cortical	JJ	O
ER	ER	NNP	O
.	.	.	O

The	the	DT	O
Erg27	Erg27	NNP	O
localization	localization	NN	O
in	in	IN	O
wild	wild	JJ	O
type	type	NN	O
cells	cell	NNS	O
is	be	VBZ	O
predominantly	predominantly	RB	O
in	in	IN	O
lipid	lipid	NN	O
droplets	droplet	NNS	O
,	,	,	O
while	while	IN	O
in	in	IN	O
rhoÂ	rhoÂ	NNS	O
°	°	NNS	O
cells	cell	VBZ	O
the	the	DT	O
enzyme	enzyme	NNS	O
is	be	VBZ	O
mainly	mainly	RB	O
in	in	IN	O
nuclear	nuclear	JJ	O
and	and	CC	O
cortical	cortical	JJ	O
endoplasmic	endoplasmic	JJ	O
reticulum	reticulum	NN	O
.	.	.	O

Wild	wild	JJ	O
type	type	NN	O
W303	W303	NNP	O
with	with	IN	O
the	the	DT	O
ERG27-GFP	ERG27-GFP	NNP	O
fusion	fusion	NN	O
integrated	integrate	VBN	O
in	in	IN	O
the	the	DT	O
genome	genome	NN	O
was	be	VBD	O
visualized	visualize	VBN	O
at	at	IN	O
fluorescence	fluorescence	NN	O
microscopy	microscopy	JJ	O
after	after	IN	O
statins	statins	NNP	O
treatments	treatment	NNS	O
,	,	,	O
pravastatin	pravastatin	NNP	O
150Âµg	150Âµg	NNP	O
/	/	SYM	O
ml	ml	NNS	O
,	,	,	O
atorvastatin	atorvastatin	VB	O
100Âµg	100âµg	CD	O
/	/	SYM	O
ml	ml	NN	O
and	and	CC	O
rosuvastatin	rosuvastatin	NNP	O
50Âµg	50âµg	CD	O
/	/	SYM	O
ml	ml	NN	O
in	in	IN	O
exponential	exponential	JJ	O
growth	growth	NN	O
phase	phase	NN	O
in	in	IN	O
YPD	YPD	NNP	O
medium	medium	NN	O
.	.	.	O

Bar	bar	NN	O
:	:	:	O
2	2	CD	O
Âµm	Âµm	NNP	O
.	.	.	O

The	the	DT	O
magnification	magnification	NN	O
is	be	VBZ	O
the	the	DT	O
same	same	JJ	O
in	in	IN	O
each	each	DT	O
picture	picture	NN	O
.	.	.	O

The	the	DT	O
yeast	yeast	NN	O
Kluyveromyces	Kluyveromyces	NNP	O
lactis	lactis	NN	O
has	have	VBZ	O
a	a	DT	O
metabolism	metabolism	NN	O
similar	similar	JJ	O
to	to	IN	O
that	that	DT	O
of	of	IN	O
human	human	JJ	O
cells	cell	NNS	O
and	and	CC	O
the	the	DT	O
regulation	regulation	NN	O
between	between	IN	O
fermentative	fermentative	JJ	O
and	and	CC	O
respiratory	respiratory	JJ	O
metabolism	metabolism	NN	O
depends	depend	VBZ	O
on	on	IN	O
oxygen	oxygen	NN	O
availability	availability	NN	O
;	;	:	O
moreover	moreover	RB	O
,	,	,	O
in	in	IN	O
K.	K.	NNP	O
lactis	lactis	NNP	O
,	,	,	O
as	as	IN	O
in	in	IN	O
human	human	JJ	O
cells	cell	NNS	O
,	,	,	O
cells	cell	NNS	O
can	can	MD	O
not	not	RB	O
survive	survive	VB	O
without	without	IN	O
mitochondrial	mitochondrial	NN	O
DNA	dna	NN	B
.	.	.	O

We	-PRON-	PRP	O
analysed	analyse	VBD	O
the	the	DT	O
effect	effect	NN	O
of	of	IN	O
statins	statin	NNS	O
on	on	IN	O
K.	K.	NNP	O
lactis	lactis	JJ	O
growth	growth	NN	O
,	,	,	O
in	in	IN	O
order	order	NN	O
to	to	TO	O
enlighten	enlighten	VB	O
the	the	DT	O
effects	effect	NNS	O
of	of	IN	O
statins	statin	NNS	O
on	on	IN	O
respiration	respiration	NN	O
in	in	IN	O
a	a	DT	O
yeast	yeast	NN	O
that	that	WDT	O
could	could	MD	O
mimic	mimic	VB	O
the	the	DT	O
human	human	JJ	O
cell	cell	NN	O
behaviour	behaviour	NN	O
.	.	.	O

The	the	DT	O
K.	K.	NNP	O
lactis	lactis	JJ	O
Îpda1	Îpda1	NNP	O
,	,	,	O
a	a	DT	O
mutant	mutant	JJ	O
strain	strain	NN	O
lacking	lack	VBG	O
the	the	DT	O
pyruvate	pyruvate	JJ	O
dehydrogenase	dehydrogenase	NN	O
E1Î±	E1Î±	NNP	O
subunit	subunit	VBN	B
,	,	,	O
was	be	VBD	O
used	use	VBN	O
to	to	TO	O
mimic	mimic	VB	O
the	the	DT	O
growth	growth	NN	O
behaviour	behaviour	NN	O
of	of	IN	O
a	a	DT	O
S.	S.	NNP	O
cerevisiae	cerevisiae	NNS	O
rhoÂ	rhoÂ	NNS	O
°	°	NNS	O
strain	strain	NN	O
.	.	.	O

Statins	Statins	NNP	O
treatments	treatment	NNS	O
resulted	result	VBD	O
in	in	IN	O
a	a	DT	O
slight	slight	JJ	O
delay	delay	NN	O
in	in	IN	O
growth	growth	NN	O
,	,	,	O
intermediate	intermediate	JJ	O
between	between	IN	O
the	the	DT	O
untreated	untreated	JJ	O
wild	wild	JJ	O
type	type	NN	O
and	and	CC	O
the	the	DT	O
Îpda1	Îpda1	NNP	O
mutant	mutant	NNP	O
strain	strain	NN	O
with	with	IN	O
a	a	DT	O
defective	defective	JJ	O
respiration	respiration	NN	O
.	.	.	O

This	this	DT	O
experiment	experiment	NN	O
demonstrated	demonstrate	VBD	O
that	that	IN	O
statins	statin	NNS	O
are	be	VBP	O
effective	effective	JJ	O
also	also	RB	O
in	in	IN	O
a	a	DT	O
yeast	yeast	NN	O
unable	unable	JJ	O
to	to	TO	O
lose	lose	VB	O
spontaneously	spontaneously	RB	O
mitochondrial	mitochondrial	NN	O
DNA	dna	NN	O
,	,	,	O
as	as	IN	O
for	for	IN	O
human	human	JJ	O
cells	cell	NNS	O
.	.	.	O

Statins	statin	NNS	O
are	be	VBP	O
not	not	RB	O
recommended	recommend	VBN	O
for	for	IN	O
patients	patient	NNS	O
affected	affect	VBN	O
by	by	IN	O
mitochondrial	mitochondrial	NN	O
diseases	disease	NNS	B
and	and	CC	O
patients	patient	NNS	O
with	with	IN	O
Mitochondrial	Mitochondrial	NNP	O
Encephalomyopathy	Encephalomyopathy	NNP	O
,	,	,	O
Lactic	Lactic	NNP	O
Acidosis	Acidosis	NNP	O
and	and	CC	O
Stroke	Stroke	NNP	O
-	-	HYPH	O
like	like	JJ	O
episodes	episode	NNS	O
experienced	experience	VBD	O
myotoxicity	myotoxicity	NN	B
,	,	,	B
.	.	.	O

A	a	DT	O
yeast	yeast	NN	O
model	model	NN	O
for	for	IN	O
MELAS	MELAS	NNP	O
mitochondrial	mitochondrial	NN	O
disease	disease	NN	O
exists	exist	VBZ	O
:	:	:	O
the	the	DT	O
strain	strain	NN	O
C25	C25	NNP	O
T	T	NNP	O
containing	contain	VBG	O
the	the	DT	O
C25	C25	NNP	O
T	T	NNP	O
mutation	mutation	NN	O
in	in	IN	O
the	the	DT	O
mitochondrial	mitochondrial	NN	O
tRNALeu	tRNALeu	NNP	O
,	,	,	O
is	be	VBZ	O
the	the	DT	O
yeast	yeast	NN	O
counterpart	counterpart	NN	O
of	of	IN	O
the	the	DT	O
human	human	JJ	O
mitochondrial	mitochondrial	NN	O
C3256	C3256	NNP	O
T	T	NNP	O
mutation	mutation	NN	O
in	in	IN	O
the	the	DT	O
tRNALeu	tRNALeu	NNP	O
gene	gene	NN	O
,	,	,	O
identified	identify	VBN	O
in	in	IN	O
MELAS	MELAS	NNP	O
patients	patient	NNS	B
.	.	.	O

The	the	DT	O
C25	C25	NNP	O
T	T	NNP	O
mitochondrial	mitochondrial	NN	O
mutation	mutation	NN	O
induces	induce	VBZ	O
a	a	DT	O
reduced	reduced	JJ	O
growth	growth	NN	O
on	on	IN	O
a	a	DT	O
respiratory	respiratory	JJ	O
carbon	carbon	NN	O
source	source	NN	O
and	and	CC	O
shows	show	VBZ	O
mitochondrial	mitochondrial	NN	O
morphology	morphology	NN	O
defects	defect	VBZ	B
.	.	.	O

In	in	IN	O
order	order	NN	O
to	to	TO	O
verify	verify	VB	O
if	if	IN	O
the	the	DT	O
effect	effect	NN	O
of	of	IN	O
statins	statin	NNS	O
treatment	treatment	NN	O
could	could	MD	O
be	be	VB	O
additive	additive	JJ	O
on	on	IN	O
the	the	DT	O
yeast	yeast	NN	O
MELAS	MELAS	NNP	O
phenotypes	phenotype	NNS	O
,	,	,	O
we	-PRON-	PRP	O
followed	follow	VBD	O
the	the	DT	O
growth	growth	NN	O
of	of	IN	O
C25	C25	NNP	O
T	T	NNP	O
cells	cell	NNS	O
with	with	IN	O
statins	statin	NNS	O
.	.	.	O

The	the	DT	O
treatment	treatment	NN	O
with	with	IN	O
statins	statin	NNS	O
causes	cause	VBZ	O
a	a	DT	O
mild	mild	JJ	O
effect	effect	NN	O
on	on	IN	O
growth	growth	NN	O
in	in	IN	O
exponential	exponential	JJ	O
phase	phase	NN	O
,	,	,	O
intermediate	intermediate	JJ	O
between	between	IN	O
rhoÂ	rhoÂ	NNS	O
°	°	NNS	O
cells	cell	NNS	O
and	and	CC	O
the	the	DT	O
non	non	JJ	O
-	-	JJ	O
treated	treated	JJ	O
mutant	mutant	NN	O
.	.	.	O

Of	of	IN	O
note	note	NN	O
,	,	,	O
pravastatin	pravastatin	NNP	O
seems	seem	VBZ	O
to	to	TO	O
exert	exert	VB	O
a	a	DT	O
greater	great	JJR	O
effect	effect	NN	O
,	,	,	O
inducing	induce	VBG	O
a	a	DT	O
lag	lag	NN	O
phase	phase	NN	O
in	in	IN	O
growth	growth	NN	O
.	.	.	O

This	this	DT	O
experiment	experiment	NN	O
showed	show	VBD	O
that	that	IN	O
statins	statin	NNS	O
exacerbated	exacerbate	VBD	O
the	the	DT	O
mitochondrial	mitochondrial	NN	O
dysfunction	dysfunction	NN	O
of	of	IN	O
a	a	DT	O
yeast	yeast	NN	O
strain	strain	NN	O
with	with	IN	O
impaired	impaired	JJ	O
mitochondrial	mitochondrial	NN	O
function	function	NN	O
.	.	.	O

In	in	IN	O
light	light	NN	O
of	of	IN	O
the	the	DT	O
evidence	evidence	NN	O
that	that	IN	O
statins	statin	VBZ	O
assumption	assumption	NN	O
is	be	VBZ	O
often	often	RB	O
associated	associate	VBN	O
with	with	IN	O
muscle	muscle	NN	O
-	-	HYPH	O
related	relate	VBN	O
side	side	NN	O
effects	effect	NNS	O
,	,	,	O
such	such	JJ	O
as	as	IN	O
fatigue	fatigue	NN	O
,	,	,	O
muscle	muscle	NN	O
pain	pain	NN	O
and	and	CC	O
muscle	muscle	NN	O
weakness	weakness	NN	O
,	,	,	O
we	-PRON-	PRP	O
sought	seek	VBD	O
to	to	TO	O
verify	verify	VB	O
the	the	DT	O
effect	effect	NN	O
of	of	IN	O
statins	statin	NNS	O
on	on	IN	O
a	a	DT	O
well	well	RB	O
-	-	HYPH	O
established	establish	VBN	O
inÂ	inÂ	NNP	O
vitro	vitro	FW	O
model	model	NN	O
of	of	IN	O
myogenesis	myogenesis	NNP	O
,	,	,	O
the	the	DT	O
C2C12	C2C12	NNP	O
murine	murine	NN	O
myoblasts	myoblast	NNS	O
cell	cell	NN	O
line	line	NN	B
.	.	.	O

To	to	IN	O
this	this	DT	O
end	end	NN	O
,	,	,	O
we	-PRON-	PRP	O
assessed	assess	VBD	O
the	the	DT	O
differentiation	differentiation	NN	O
capacity	capacity	NN	O
of	of	IN	O
C2C12	C2C12	NNS	O
upon	upon	IN	O
atorvastatin	atorvastatin	NNP	O
25âÂµM	25ââµm	CD	O
treatment	treatment	NN	O
,	,	,	O
as	as	IN	O
compared	compare	VBN	O
to	to	IN	O
untreated	untreated	JJ	O
cells	cell	NNS	O
by	by	IN	O
immunofluorescence	immunofluorescence	NN	O
for	for	IN	O
Myosin	Myosin	NNP	O
heavy	heavy	JJ	O
chain	chain	NN	O
,	,	,	O
a	a	DT	O
marker	marker	NN	O
of	of	IN	O
terminal	terminal	JJ	O
myogenic	myogenic	JJ	O
differentiation	differentiation	NN	O
.	.	.	O

As	as	IN	O
shown	show	VBN	O
in	in	IN	O
Figure	Figure	NNP	O
6	6	CD	O
,	,	,	O
atorvastatin	atorvastatin	VB	O
dramatically	dramatically	RB	O
reduced	reduce	VBN	O
C2C12	c2c12	JJ	O
myogenic	myogenic	NN	O
differentiation	differentiation	NN	O
Figure	Figure	NNP	O
6	6	CD	O
,	,	,	O
as	as	IN	O
quantified	quantify	VBN	O
evaluating	evaluate	VBG	O
differentiation	differentiation	NN	O
index	index	NN	O
Figure	Figure	NNP	O
6	6	CD	O
.	.	.	O

To	to	TO	O
verify	verify	VB	O
if	if	IN	O
the	the	DT	O
observed	observe	VBN	O
differentiation	differentiation	NN	O
defects	defect	NNS	O
were	be	VBD	O
also	also	RB	O
accompanied	accompany	VBN	O
with	with	IN	O
mitochondrial	mitochondrial	NN	O
dysfunction	dysfunction	NN	O
,	,	,	O
we	-PRON-	PRP	O
measured	measure	VBD	O
the	the	DT	O
mitochondrial	mitochondrial	NN	O
DNA	dna	NN	O
content	content	NN	O
by	by	IN	O
qRT	qRT	NNP	O
-	-	:	O
PCR	PCR	NNP	O
.	.	.	O

The	the	DT	O
threshold	threshold	NN	O
of	of	IN	O
amplification	amplification	NN	O
between	between	IN	O
mtDNA	mtDNA	NNP	O
and	and	CC	O
nuclear	nuclear	JJ	O
DNA	DNA	NNP	O
was	be	VBD	O
measured	measure	VBN	O
;	;	:	O
the	the	DT	O
average	average	NN	O
of	of	IN	O
ratio	ratio	NN	O
of	of	IN	O
treated	treat	VBN	O
/	/	SYM	O
non	non	JJ	O
-	-	JJ	O
treated	treat	VBN	O
was	be	VBD	O
0.96âÂ±â0.015	0.96ââ±â0.015	CD	O
meanâÂ±âstandard	meanâÂ±âstandard	NNP	O
deviation	deviation	NN	O
mean	mean	NN	O
of	of	IN	O
nâ=â4	nâ=â4	NNP	O
replicates	replicate	NNS	O
,	,	,	O
indicated	indicate	VBD	O
that	that	IN	O
atorvastatin	atorvastatin	NN	O
induced	induce	VBD	O
a	a	DT	O
dose	dose	RB	O
-	-	HYPH	O
dependent	dependent	JJ	O
reduction	reduction	NN	O
of	of	IN	O
mitochondrial	mitochondrial	NN	O
DNA	dna	NN	O
,	,	,	O
in	in	IN	O
agreement	agreement	NN	O
with	with	IN	O
data	datum	NNS	O
obtained	obtain	VBN	O
in	in	IN	O
yeast	yeast	NN	O
cells	cell	NNS	O
.	.	.	O

Statins	Statins	NNP	O
block	block	NN	O
C2C12	c2c12	JJ	O
differentiation	differentiation	NN	O
and	and	CC	O
induce	induce	VBP	O
loss	loss	NN	O
of	of	IN	O
mtDNA	mtdna	NN	O
.	.	.	O

C2C12	C2C12	NNP	O
were	be	VBD	O
treated	treat	VBN	O
for	for	IN	O
48	48	CD	O
with	with	IN	O
25uM	25um	CD	O
atorvastatin	atorvastatin	NN	O
in	in	IN	O
growth	growth	NN	O
medium	medium	NN	O
and	and	CC	O
then	then	RB	O
induced	induce	VBN	O
to	to	TO	O
differentiate	differentiate	VB	O
for	for	IN	O
further	further	JJ	O
48h	48h	NNS	O
either	either	RB	O
.	.	.	O

Non	non	JJ	O
-	-	HYPH	O
treated	treat	VBN	O
cells	cell	NNS	O
were	be	VBD	O
used	use	VBN	O
as	as	IN	O
a	a	DT	O
control	control	NN	O
.	.	.	O

Representative	representative	JJ	O
images	image	NNS	O
of	of	IN	O
immunofluorescence	immunofluorescence	NN	O
for	for	IN	O
Myosin	Myosin	NNP	O
Heavy	Heavy	NNP	O
Chain	Chain	NNP	O
are	be	VBP	O
shown	show	VBN	O
.	.	.	O

Nuclei	nucleus	NNS	O
were	be	VBD	O
counterstained	counterstaine	VBN	O
with	with	IN	O
DAPI	dapi	NN	O
.	.	.	O

Graph	Graph	NNP	O
shows	show	VBZ	O
the	the	DT	O
quantification	quantification	NN	O
of	of	IN	O
the	the	DT	O
percentage	percentage	NN	O
of	of	IN	O
nuclei	nucleus	NNS	O
inside	inside	IN	O
MyHC	myhc	NN	O
positive	positive	JJ	O
myotubes	myotube	NNS	O
.	.	.	O

Data	datum	NNS	O
are	be	VBP	O
presented	present	VBN	O
as	as	IN	O
the	the	DT	O
average	average	NN	O
of	of	IN	O
n=3	n=3	NN	O
replicates	replicate	NNS	O
+	+	SYM	O
/-	/-	.	O
SD	sd	NN	O
.	.	.	O

Significance	significance	NN	O
has	have	VBZ	O
been	be	VBN	O
assessed	assess	VBN	O
by	by	IN	O
t	t	NN	O
-	-	HYPH	O
test	test	NN	O
.	.	.	O

Statin	statin	NN	O
intolerance	intolerance	NN	O
is	be	VBZ	O
often	often	RB	O
a	a	DT	O
consequence	consequence	NN	O
of	of	IN	O
statin	statin	NN	O
-	-	HYPH	O
associated	associate	VBN	O
myopathy	myopathy	NNP	B
,	,	,	B
;	;	:	O
hence	hence	RB	O
,	,	,	O
it	-PRON-	PRP	O
is	be	VBZ	O
fundamental	fundamental	JJ	O
to	to	TO	O
understand	understand	VB	O
the	the	DT	O
molecular	molecular	JJ	O
effect	effect	NN	O
of	of	IN	O
statin	statin	NN	O
in	in	IN	O
the	the	DT	O
cells	cell	NNS	O
.	.	.	O

Yeast	yeast	NN	O
is	be	VBZ	O
recognised	recognise	VBN	O
as	as	IN	O
a	a	DT	O
good	good	JJ	O
model	model	NN	O
to	to	TO	O
study	study	VB	O
the	the	DT	O
cellular	cellular	JJ	O
mechanisms	mechanism	NNS	O
of	of	IN	O
mitochondrial	mitochondrial	JJ	O
human	human	JJ	O
diseases	disease	NNS	O
and	and	CC	O
S.	S.	NNP	O
cerevisiae	cerevisiae	NNS	O
is	be	VBZ	O
unique	unique	JJ	O
among	among	IN	O
yeasts	yeast	NNS	O
because	because	IN	O
it	-PRON-	PRP	O
is	be	VBZ	O
able	able	JJ	O
to	to	TO	O
survive	survive	VB	O
with	with	IN	O
non	non	JJ	O
-	-	JJ	O
functional	functional	JJ	O
mitochondria	mitochondria	NN	B
.	.	.	O

We	-PRON-	PRP	O
confirmed	confirm	VBD	O
here	here	RB	O
that	that	IN	O
statins	statins	NNP	O
act	act	VBP	O
as	as	IN	O
cholesterol	cholesterol	NN	O
lowering	lower	VBG	O
drugs	drug	NNS	O
in	in	IN	O
S.	S.	NNP	O
cerevisiae	cerevisiae	NNS	O
as	as	IN	O
was	be	VBD	O
previously	previously	RB	O
published	publish	VBN	B
;	;	:	O
mass	mass	NN	O
spectrometry	spectrometry	NN	O
analysis	analysis	NN	O
revealed	reveal	VBD	O
a	a	DT	O
lower	low	JJR	O
ergosterol	ergosterol	JJ	O
content	content	NN	O
in	in	IN	O
statins	statin	NNS	O
treated	treat	VBN	O
cells	cell	NNS	O
than	than	IN	O
the	the	DT	O
wild	wild	JJ	O
type	type	NN	O
strain	strain	NN	O
;	;	:	O
in	in	IN	O
yeast	yeast	NN	O
cells	cell	NNS	O
treated	treat	VBN	O
with	with	IN	O
statins	statin	NNS	O
,	,	,	O
the	the	DT	O
Erg27	Erg27	NNP	O
enzyme	enzyme	NNS	O
localised	localise	VBN	O
in	in	IN	O
the	the	DT	O
endoplasmic	endoplasmic	JJ	O
reticulum	reticulum	NN	O
indicating	indicate	VBG	O
low	low	JJ	O
level	level	NN	O
of	of	IN	O
ergosterol	ergosterol	NN	O
,	,	,	O
because	because	IN	O
in	in	IN	O
cells	cell	NNS	O
with	with	IN	O
normal	normal	JJ	O
ergosterol	ergosterol	JJ	O
content	content	NN	O
,	,	,	O
the	the	DT	O
enzyme	enzyme	NNS	O
is	be	VBZ	O
localised	localise	VBN	O
in	in	IN	O
lipid	lipid	NN	O
droplets	droplet	NNS	B
.	.	.	O

Of	of	IN	O
note	note	NN	O
,	,	,	O
statin	statin	NN	O
treatments	treatment	NNS	O
resulted	result	VBD	O
in	in	IN	O
W303	W303	NNP	O
growth	growth	NN	O
curves	curve	NNS	O
rates	rate	NNS	O
intermediate	intermediate	JJ	O
between	between	IN	O
the	the	DT	O
non	non	JJ	O
-	-	JJ	O
treated	treated	JJ	O
strain	strain	NN	O
and	and	CC	O
the	the	DT	O
strain	strain	NN	O
devoid	devoid	NN	O
of	of	IN	O
mitochondrial	mitochondrial	NN	O
DNA	dna	NN	O
W303	W303	NNP	O
rhoÂ	rhoÂ	NNS	O
°	°	NNS	O
,	,	,	O
while	while	IN	O
the	the	DT	O
supply	supply	NN	O
of	of	IN	O
ergosterol	ergosterol	NN	O
in	in	IN	O
the	the	DT	O
medium	medium	NN	O
restores	restore	VBZ	O
a	a	DT	O
wild	wild	JJ	O
type	type	NN	O
growth	growth	NN	O
in	in	IN	O
statin	statin	NN	O
treated	treat	VBN	O
cells	cell	NNS	O
and	and	CC	O
in	in	IN	O
W303	w303	JJ	O
rhoÂ	rhoÂ	NNS	O
°	°	NNS	O
Supplementary	Supplementary	NNP	O
Figure	Figure	NNP	O
3	3	CD	O
.	.	.	O

Also	also	RB	O
,	,	,	O
the	the	DT	O
growth	growth	NN	O
curves	curve	NNS	O
of	of	IN	O
the	the	DT	O
yeast	yeast	NN	O
K.	K.	NNP	O
lactis	lactis	NNP	O
,	,	,	O
which	which	WDT	O
has	have	VBZ	O
a	a	DT	O
metabolism	metabolism	NN	O
more	more	RBR	O
similar	similar	JJ	O
to	to	IN	O
human	human	JJ	O
cells	cell	NNS	O
,	,	,	O
revealed	reveal	VBD	O
that	that	IN	O
statins	statin	NNS	O
slightly	slightly	RB	O
impair	impair	VBP	O
the	the	DT	O
growth	growth	NN	O
,	,	,	O
as	as	IN	O
in	in	IN	O
S.	S.	NNP	O
cerevisiae	cerevisiae	NNS	O
.	.	.	O

Finally	finally	RB	O
,	,	,	O
we	-PRON-	PRP	O
treated	treat	VBD	O
with	with	IN	O
statins	statin	NNS	O
a	a	DT	O
yeast	yeast	NN	O
model	model	NN	O
of	of	IN	O
human	human	JJ	O
MELAS	MELAS	NNP	O
disease	disease	NN	B
.	.	.	O

Statins	statin	NNS	O
are	be	VBP	O
not	not	RB	O
administered	administer	VBN	O
to	to	IN	O
MELAS	MELAS	NNP	O
patients	patient	NNS	O
because	because	IN	O
they	-PRON-	PRP	O
precipitate	precipitate	VBP	O
myopathic	myopathic	JJ	O
symptoms	symptom	NNS	B
;	;	:	O
indeed	indeed	RB	O
,	,	,	O
we	-PRON-	PRP	O
found	find	VBD	O
an	an	DT	O
effect	effect	NN	O
on	on	IN	O
C25	C25	NNP	O
T	t	NN	O
strain	strain	VBP	O
growth	growth	NN	O
,	,	,	O
indicating	indicate	VBG	O
an	an	DT	O
additive	additive	JJ	O
negative	negative	JJ	O
affect	affect	NN	O
of	of	IN	O
stations	station	NNS	O
if	if	IN	O
associated	associate	VBN	O
with	with	IN	O
a	a	DT	O
MELAS	MELAS	NNP	O
mutation	mutation	NN	O
.	.	.	O

Taking	take	VBG	O
together	together	RB	O
these	these	DT	O
results	result	NNS	O
indicate	indicate	VBP	O
that	that	IN	O
S.	S.	NNP	O
cerevisiae	cerevisiae	NNS	O
is	be	VBZ	O
a	a	DT	O
suitable	suitable	JJ	O
model	model	NN	O
to	to	TO	O
investigate	investigate	VB	O
the	the	DT	O
mitochondrial	mitochondrial	JJ	O
effects	effect	NNS	O
of	of	IN	O
statins	statin	NNS	O
and	and	CC	O
also	also	RB	O
to	to	TO	O
enlighten	enlighten	VB	O
the	the	DT	O
regulation	regulation	NN	O
of	of	IN	O
ergosterol	ergosterol	JJ	O
pathway	pathway	NN	O
based	base	VBN	O
on	on	IN	O
the	the	DT	O
dynamic	dynamic	JJ	O
localisation	localisation	NN	O
of	of	IN	O
Erg	Erg	NNP	O
enzymes	enzyme	NNS	O
in	in	IN	O
the	the	DT	O
cell	cell	NN	O
.	.	.	O

Another	another	DT	O
case	case	NN	O
of	of	IN	O
relocalization	relocalization	NN	O
of	of	IN	O
an	an	DT	O
enzyme	enzyme	NNS	O
of	of	IN	O
the	the	DT	O
ergosterol	ergosterol	JJ	O
biosynthetic	biosynthetic	JJ	O
pathway	pathway	NN	O
was	be	VBD	O
previously	previously	RB	O
described	describe	VBN	O
:	:	:	O
Erg1	Erg1	NNP	O
shows	show	VBZ	O
a	a	DT	O
dual	dual	JJ	O
localisation	localisation	NN	O
both	both	CC	O
in	in	IN	O
the	the	DT	O
ER	ER	NNP	O
and	and	CC	O
LDs	ld	NNS	O
,	,	,	O
but	but	CC	O
it	-PRON-	PRP	O
is	be	VBZ	O
redistributed	redistribute	VBN	O
from	from	IN	O
LDs	ld	NNS	O
to	to	IN	O
ER	ER	NNP	O
in	in	IN	O
low	low	JJ	O
iron	iron	NN	O
condition	condition	NN	O
in	in	IN	O
the	the	DT	O
cells	cell	NNS	B
.	.	.	O

The	the	DT	O
cross	cross	NN	O
talk	talk	NN	O
between	between	IN	O
the	the	DT	O
mitochondrial	mitochondrial	NN	O
respiration	respiration	NN	O
and	and	CC	O
the	the	DT	O
ergosterol	ergosterol	JJ	O
biosynthetic	biosynthetic	JJ	O
pathway	pathway	NN	O
is	be	VBZ	O
still	still	RB	O
poorly	poorly	RB	O
understood	understand	VBN	B
.	.	.	O

Statins	statin	NNS	O
induce	induce	VBP	O
a	a	DT	O
petite	petite	JJ	O
phenotype	phenotype	NN	O
Figure	figure	NN	O
1and	1and	NNP	O
Supplementary	Supplementary	NNP	O
Figure	Figure	NNP	O
2	2	CD	O
,	,	,	O
caused	cause	VBN	O
by	by	IN	O
the	the	DT	O
loss	loss	NN	O
of	of	IN	O
mitochondrial	mitochondrial	NN	O
DNA	dna	NN	O
;	;	:	O
S.	S.	NNP	O
cerevisiae	cerevisiae	NNS	O
is	be	VBZ	O
able	able	JJ	O
to	to	TO	O
survive	survive	VB	O
without	without	IN	O
mitochondrial	mitochondrial	NN	O
DNA	dna	NN	O
rhoÂ	rhoÂ	NNS	O
°	°	NNS	O
cells	cell	NNS	O
but	but	CC	O
can	can	MD	O
also	also	RB	O
maintain	maintain	VB	O
rearrangements	rearrangement	NNS	O
of	of	IN	O
mitochondrial	mitochondrial	NN	O
DNA	dna	NN	O
rhoâ	rhoâ	NNP	O
cells	cell	NNS	O
,	,	,	O
induced	induce	VBN	O
by	by	IN	O
chemical	chemical	JJ	O
agents	agent	NNS	O
or	or	CC	O
by	by	IN	O
genetic	genetic	JJ	O
mutations	mutation	NNS	B
.	.	.	O

The	the	DT	O
lack	lack	NN	O
of	of	IN	O
mitochondrial	mitochondrial	JJ	O
DNA	dna	NN	O
in	in	IN	O
statin	statin	NN	O
treated	treat	VBN	O
cells	cell	NNS	O
,	,	,	O
suggested	suggest	VBD	O
an	an	DT	O
effect	effect	NN	O
of	of	IN	O
statins	statin	NNS	O
in	in	IN	O
the	the	DT	O
stability	stability	NN	O
of	of	IN	O
mitochondrial	mitochondrial	NN	O
DNA	dna	NN	O
and	and	CC	O
not	not	RB	O
in	in	IN	O
mitochondrial	mitochondrial	JJ	O
DNA	dna	NN	O
transcription	transcription	NN	O
/	/	SYM	O
replication	replication	NN	O
/	/	SYM	O
recombination	recombination	NN	O
.	.	.	O

The	the	DT	O
percentage	percentage	NN	O
of	of	IN	O
treated	treat	VBN	O
cells	cell	NNS	O
showing	show	VBG	O
cells	cell	NNS	O
devoid	devoid	JJ	O
of	of	IN	O
mitochondrial	mitochondrial	NN	O
DNA	dna	NN	O
Figure	figure	NN	O
2	2	CD	O
fits	fit	VBZ	O
well	well	RB	O
with	with	IN	O
the	the	DT	O
percentage	percentage	NN	O
of	of	IN	O
petite	petite	JJ	O
colonies	colony	NNS	O
Figure	figure	NN	O
1	1	CD	O
.	.	.	O

The	the	DT	O
supplementation	supplementation	NN	O
of	of	IN	O
ergosterol	ergosterol	NN	O
in	in	IN	O
the	the	DT	O
growth	growth	NN	O
medium	medium	NN	O
was	be	VBD	O
able	able	JJ	O
to	to	TO	O
suppress	suppress	VB	O
the	the	DT	O
mitochondrial	mitochondrial	NN	O
DNA	dna	NN	O
loss	loss	NN	O
Figures	figure	NNS	O
1and	1and	NNP	O
2	2	CD	O
,	,	,	O
demonstrating	demonstrate	VBG	O
that	that	IN	O
a	a	DT	O
correct	correct	JJ	O
amount	amount	NN	O
of	of	IN	O
ergosterol	ergosterol	NN	O
is	be	VBZ	O
essential	essential	JJ	O
for	for	IN	O
mitochondrial	mitochondrial	NN	O
function	function	NN	O
.	.	.	O

To	to	IN	O
date	date	NN	O
,	,	,	O
a	a	DT	O
demonstration	demonstration	NN	O
of	of	IN	O
how	how	WRB	O
mitochondrial	mitochondrial	JJ	O
DNA	DNA	NNP	O
molecules	molecule	NNS	O
are	be	VBP	O
attached	attach	VBN	O
to	to	IN	O
the	the	DT	O
inner	inner	JJ	O
mitochondrial	mitochondrial	NN	O
membrane	membrane	NN	O
is	be	VBZ	O
still	still	RB	O
lacking	lack	VBG	O
,	,	,	O
but	but	CC	O
lipid	lipid	NN	O
rafts	raft	NNS	O
,	,	,	O
membrane	membrane	NN	O
microdomains	microdomain	NNS	O
enriched	enrich	VBN	O
in	in	IN	O
cholesterol	cholesterol	NN	O
and	and	CC	O
sphingolipids	sphingolipid	NNS	B
are	be	VBP	O
essential	essential	JJ	O
to	to	TO	O
maintain	maintain	VB	O
mitochondrial	mitochondrial	JJ	O
DNA	dna	NN	O
in	in	IN	O
human	human	JJ	O
cells	cell	NNS	B
.	.	.	O

Furthermore	furthermore	RB	O
,	,	,	O
the	the	DT	O
maintenance	maintenance	NN	O
of	of	IN	O
mitochondrial	mitochondrial	NN	O
nucleoids	nucleoid	NNS	O
is	be	VBZ	O
coordinated	coordinate	VBN	O
with	with	IN	O
the	the	DT	O
mitochondrial	mitochondrial	NN	O
fusion	fusion	NN	O
and	and	CC	O
fission	fission	NN	O
machinery	machinery	NN	O
to	to	TO	O
ensure	ensure	VB	O
the	the	DT	O
distribution	distribution	NN	O
of	of	IN	O
mitochondrial	mitochondrial	NN	O
DNA	dna	NN	O
in	in	IN	O
the	the	DT	O
cells	cell	NNS	B
;	;	:	O
of	of	IN	O
note	note	NN	O
,	,	,	O
the	the	DT	O
mitochondrial	mitochondrial	NN	O
protein	protein	NN	O
ATAD3	ATAD3	NNP	O
,	,	,	O
which	which	WDT	O
binds	bind	VBZ	O
cholesterol	cholesterol	NN	O
in	in	IN	O
the	the	DT	O
inner	inner	JJ	O
mitochondrial	mitochondrial	NN	O
membrane	membrane	NN	O
,	,	,	O
has	have	VBZ	O
been	be	VBN	O
proposed	propose	VBN	O
to	to	TO	O
have	have	VB	O
a	a	DT	O
central	central	JJ	O
role	role	NN	O
in	in	IN	O
nucleoid	nucleoid	JJ	O
organisation	organisation	NN	B
.	.	.	O

The	the	DT	O
statins	statin	NNS	O
investigated	investigate	VBN	O
in	in	IN	O
this	this	DT	O
work	work	NN	O
showed	show	VBD	O
different	different	JJ	O
behaviours	behaviour	NNS	O
:	:	:	O
pravastatin	pravastatin	NNP	O
produced	produce	VBD	O
less	less	JJR	O
petites	petite	NNS	O
,	,	,	O
it	-PRON-	PRP	O
is	be	VBZ	O
less	less	RBR	O
toxic	toxic	JJ	O
,	,	,	O
but	but	CC	O
the	the	DT	O
ergosterol	ergosterol	JJ	O
content	content	NN	O
is	be	VBZ	O
comparable	comparable	JJ	O
to	to	IN	O
other	other	JJ	O
statins	statin	NNS	O
,	,	,	O
and	and	CC	O
the	the	DT	O
respiration	respiration	NN	O
is	be	VBZ	O
more	more	RBR	O
similar	similar	JJ	O
to	to	IN	O
the	the	DT	O
wild	wild	JJ	O
type	type	NN	O
strain	strain	NN	O
.	.	.	O

Rosuvastatin	Rosuvastatin	NNP	O
produced	produce	VBD	O
the	the	DT	O
higher	high	JJR	O
percentage	percentage	NN	O
of	of	IN	O
petites	petite	NNS	O
and	and	CC	O
it	-PRON-	PRP	O
is	be	VBZ	O
more	more	RBR	O
toxic	toxic	JJ	O
,	,	,	O
and	and	CC	O
the	the	DT	O
respiration	respiration	NN	O
is	be	VBZ	O
similar	similar	JJ	O
to	to	IN	O
rhoÂ	rhoÂ	NNS	O
°	°	NNS	O
cells	cell	NNS	O
.	.	.	O

Atorvastatin	Atorvastatin	NNP	O
is	be	VBZ	O
intermediate	intermediate	JJ	O
between	between	IN	O
pravastatin	pravastatin	NNP	O
and	and	CC	O
rosuvastatin	rosuvastatin	NN	O
.	.	.	O

The	the	DT	O
same	same	JJ	O
behaviour	behaviour	NN	O
is	be	VBZ	O
observed	observe	VBN	O
when	when	WRB	O
K.	K.	NNP	O
lactis	lactis	NNP	O
was	be	VBD	O
treated	treat	VBN	O
with	with	IN	O
the	the	DT	O
statins	statin	NNS	O
.	.	.	O

An	an	DT	O
extensive	extensive	JJ	O
literature	literature	NN	O
reports	report	NNS	O
defects	defect	NNS	O
in	in	IN	O
respiration	respiration	NN	O
in	in	IN	O
mammalian	mammalian	JJ	O
cells	cell	NNS	O
treated	treat	VBN	O
with	with	IN	O
statins	statin	NNS	O
,	,	,	O
by	by	IN	O
measuring	measure	VBG	O
the	the	DT	O
activity	activity	NN	O
of	of	IN	O
respiratory	respiratory	JJ	O
chain	chain	NN	O
complexes	complex	NNS	B
.	.	.	O

We	-PRON-	PRP	O
hypothesise	hypothesise	VBP	O
that	that	IN	O
the	the	DT	O
mitochondrial	mitochondrial	NN	O
defects	defect	NNS	O
described	describe	VBN	O
in	in	IN	O
literature	literature	NN	O
can	can	MD	O
be	be	VB	O
reconciled	reconcile	VBN	O
/	/	SYM	O
explained	explain	VBN	O
by	by	IN	O
the	the	DT	O
low	low	JJ	O
levels	level	NNS	O
of	of	IN	O
mitochondrial	mitochondrial	NN	O
DNA	dna	NN	O
copy	copy	NN	O
number	number	NN	O
,	,	,	O
that	that	WDT	O
imbalance	imbalance	VBP	O
the	the	DT	O
ratio	ratio	NN	O
between	between	IN	O
mitochondrial	mitochondrial	NN	O
and	and	CC	O
nuclear	nuclear	NN	O
-	-	HYPH	O
encoded	encode	VBN	O
subunits	subunit	NNS	O
of	of	IN	O
the	the	DT	O
respiratory	respiratory	JJ	O
complexes	complex	NNS	O
,	,	,	O
resulting	result	VBG	O
in	in	IN	O
an	an	DT	O
altered	altered	JJ	O
respiration	respiration	NN	O
rate	rate	NN	O
.	.	.	O

Indeed	indeed	RB	O
,	,	,	O
yeast	yeast	NN	O
cells	cell	NNS	O
treated	treat	VBN	O
with	with	IN	O
statins	statin	NNS	O
showed	show	VBD	O
a	a	DT	O
respiration	respiration	NN	O
rate	rate	NN	O
lower	low	JJR	O
than	than	IN	O
the	the	DT	O
wild	wild	JJ	O
type	type	NN	O
strain	strain	NN	O
but	but	CC	O
,	,	,	O
when	when	WRB	O
the	the	DT	O
same	same	JJ	O
cultures	culture	NNS	O
were	be	VBD	O
grown	grow	VBN	O
in	in	IN	O
YPD	YPD	NNP	O
medium	medium	NN	O
were	be	VBD	O
supplemented	supplement	VBN	O
with	with	IN	O
ergosterol	ergosterol	NN	O
,	,	,	O
the	the	DT	O
respiration	respiration	NN	O
rate	rate	NN	O
was	be	VBD	O
higher	high	JJR	O
.	.	.	O

Of	of	IN	O
note	note	NN	O
,	,	,	O
the	the	DT	O
complex	complex	JJ	O
II	II	NNP	O
is	be	VBZ	O
the	the	DT	O
only	only	JJ	O
to	to	TO	O
be	be	VB	O
entirely	entirely	RB	O
nuclear	nuclear	JJ	O
encoded	encode	VBN	O
;	;	:	O
indeed	indeed	RB	O
,	,	,	O
the	the	DT	O
complex	complex	JJ	O
II	II	NNP	O
resulted	result	VBD	O
unaffected	unaffected	JJ	O
by	by	IN	O
simvastatin	simvastatin	JJ	O
treatment	treatment	NN	O
on	on	IN	O
skeletal	skeletal	JJ	O
muscle	muscle	NN	B
,	,	,	B
;	;	:	O
on	on	IN	O
the	the	DT	O
contrary	contrary	NN	O
,	,	,	O
the	the	DT	O
other	other	JJ	O
respiratory	respiratory	JJ	O
complexes	complex	NNS	O
contain	contain	VBP	O
nuclear	nuclear	JJ	O
and	and	CC	O
mitochondrial-	mitochondrial-	JJ	O
encoded	encoded	JJ	O
subunits	subunit	NNS	O
are	be	VBP	O
affected	affect	VBN	O
by	by	IN	O
statins	statin	NNS	B
;	;	:	O
we	-PRON-	PRP	O
hypothesise	hypothesise	VBP	O
that	that	IN	O
a	a	DT	O
reduced	reduce	VBN	O
level	level	NN	O
of	of	IN	O
mitochondrial	mitochondrial	NN	O
DNA	dna	NN	O
could	could	MD	O
results	result	NNS	O
in	in	IN	O
an	an	DT	O
imbalance	imbalance	NN	O
of	of	IN	O
the	the	DT	O
nuclear	nuclear	NN	O
and	and	CC	O
mitochondrial	mitochondrial	NN	O
encoded	encode	VBN	O
subunits	subunit	NNS	O
,	,	,	O
causing	cause	VBG	O
an	an	DT	O
altered	alter	VBN	O
respiration	respiration	NN	O
rate	rate	NN	O
.	.	.	O

Of	of	IN	O
note	note	NN	O
,	,	,	O
skeletal	skeletal	JJ	O
muscle	muscle	NN	O
biopsies	biopsy	NNS	O
from	from	IN	O
patients	patient	NNS	O
diagnosed	diagnose	VBN	O
with	with	IN	O
myopathies	myopathy	NNS	O
induced	induce	VBN	O
by	by	IN	O
statins	statin	NNS	O
,	,	,	O
were	be	VBD	O
used	use	VBN	O
to	to	TO	O
quantify	quantify	VB	O
mitochondrial	mitochondrial	NN	O
DNA	dna	NN	O
relative	relative	JJ	O
to	to	IN	O
nuclear	nuclear	JJ	O
DNA	dna	NN	O
by	by	IN	O
qPCR	qpcr	NN	O
,	,	,	O
and	and	CC	O
it	-PRON-	PRP	O
was	be	VBD	O
found	find	VBN	O
that	that	IN	O
skeletal	skeletal	JJ	O
muscle	muscle	NN	O
mitochondrial	mitochondrial	NN	O
DNA	DNA	NNP	O
is	be	VBZ	O
decreased	decrease	VBN	O
in	in	IN	O
patients	patient	NNS	O
with	with	IN	O
statin	statin	NN	O
-	-	HYPH	O
induced	induce	VBN	O
myopathy	myopathy	JJ	B
,	,	,	B
.	.	.	O

In	in	IN	O
agreement	agreement	NN	O
with	with	IN	O
this	this	DT	O
,	,	,	O
we	-PRON-	PRP	O
observed	observe	VBD	O
a	a	DT	O
small	small	JJ	O
but	but	CC	O
significant	significant	JJ	O
reduction	reduction	NN	O
of	of	IN	O
mitochondrial	mitochondrial	NN	O
DNA	dna	NN	O
in	in	IN	O
C2C12	C2C12	NNP	O
myoblasts	myoblast	NNS	O
after	after	IN	O
statin	statin	NN	O
treatment	treatment	NN	O
.	.	.	O

This	this	DT	O
reduction	reduction	NN	O
could	could	MD	O
explain	explain	VB	O
why	why	WRB	O
muscle	muscle	NN	O
cells	cell	NNS	O
are	be	VBP	O
more	more	RBR	O
sensitive	sensitive	JJ	O
to	to	IN	O
statins	statin	NNS	O
than	than	IN	O
other	other	JJ	O
cells	cell	NNS	O
,	,	,	O
resulting	result	VBG	O
in	in	IN	O
muscle	muscle	NN	O
-	-	HYPH	O
related	relate	VBN	O
side	side	NN	O
effects	effect	NNS	O
.	.	.	O

Indeed	indeed	RB	O
,	,	,	O
mitophagy	mitophagy	NNP	O
has	have	VBZ	O
been	be	VBN	O
reported	report	VBN	O
to	to	TO	O
be	be	VB	O
essential	essential	JJ	O
for	for	IN	O
proper	proper	JJ	O
muscle	muscle	NN	O
differentiation	differentiation	NN	B
and	and	CC	O
during	during	IN	O
muscle	muscle	NN	O
differentiation	differentiation	NN	O
,	,	,	O
4	4	CD	O
times	time	NNS	O
more	more	JJR	O
DNA	dna	NN	O
and	and	CC	O
8	8	CD	O
times	time	NNS	O
more	more	JJR	O
respiratory	respiratory	JJ	O
complexes	complex	NNS	O
are	be	VBP	O
needed	need	VBN	O
compared	compare	VBN	O
to	to	IN	O
other	other	JJ	O
cells	cell	NNS	B
.	.	.	O

Our	-PRON-	PRP$	O
results	result	NNS	O
support	support	VBP	O
the	the	DT	O
notion	notion	NN	O
that	that	IN	O
the	the	DT	O
amount	amount	NN	O
of	of	IN	O
mitochondrial	mitochondrial	NN	O
DNA	dna	NN	O
is	be	VBZ	O
critical	critical	JJ	O
in	in	IN	O
muscle	muscle	NN	O
differentiation	differentiation	NN	O
because	because	IN	O
after	after	IN	O
degradation	degradation	NN	O
of	of	IN	O
mitochondria	mitochondria	NNP	O
,	,	,	O
new	new	JJ	O
mitochondrial	mitochondrial	NN	O
DNA	dna	NN	O
synthesis	synthesis	NN	O
and	and	CC	O
new	new	JJ	O
membranes	membrane	NNS	O
are	be	VBP	O
needed	need	VBN	O
to	to	TO	O
maintain	maintain	VB	O
functional	functional	JJ	O
myofibers	myofiber	NNS	O
.	.	.	O

The	the	DT	O
statins	statin	NNS	O
-	-	HYPH	O
induced	induce	VBN	O
reduction	reduction	NN	O
of	of	IN	O
the	the	DT	O
amount	amount	NN	O
of	of	IN	O
cholesterol	cholesterol	NN	O
necessary	necessary	JJ	O
to	to	TO	O
maintain	maintain	VB	O
mitochondrial	mitochondrial	NN	O
DNA	dna	NN	O
,	,	,	O
and	and	CC	O
for	for	IN	O
membrane	membrane	NN	O
construction	construction	NN	O
,	,	,	O
might	may	MD	O
be	be	VB	O
the	the	DT	O
reason	reason	NN	O
why	why	WRB	O
chronic	chronic	JJ	O
statins	statin	NNS	O
treatment	treatment	NN	O
induces	induce	NNS	O
muscle	muscle	NN	O
-	-	HYPH	O
related	relate	VBN	O
side	side	NN	O
effects	effect	NNS	O
.	.	.	O

Accordingly	accordingly	RB	O
,	,	,	O
in	in	IN	O
presence	presence	NN	O
of	of	IN	O
statins	statin	NNS	O
the	the	DT	O
differentiation	differentiation	NN	O
from	from	IN	O
myoblast	myoblast	NN	O
to	to	IN	O
myotubes	myotube	NNS	O
is	be	VBZ	O
dramatically	dramatically	RB	O
reduced	reduce	VBN	O
.	.	.	O

In	in	IN	O
conclusion	conclusion	NN	O
,	,	,	O
we	-PRON-	PRP	O
have	have	VBP	O
used	use	VBN	O
S.	S.	NNP	O
cerevisiae	cerevisiae	NNS	O
as	as	IN	O
a	a	DT	O
model	model	NN	O
to	to	TO	O
study	study	VB	O
the	the	DT	O
mechanism	mechanism	NN	O
of	of	IN	O
statin	statin	NN	O
side	side	NN	O
effects	effect	NNS	O
on	on	IN	O
mitochondria	mitochondria	NNP	O
,	,	,	O
and	and	CC	O
we	-PRON-	PRP	O
confirm	confirm	VBP	O
that	that	IN	O
a	a	DT	O
relevant	relevant	JJ	O
effect	effect	NN	O
of	of	IN	O
low	low	JJ	O
cholesterol	cholesterol	NN	O
level	level	NN	O
induced	induce	VBN	O
by	by	IN	O
statins	statin	NNS	O
is	be	VBZ	O
on	on	IN	O
mitochondrial	mitochondrial	NN	O
DNA	dna	NN	O
stability	stability	NN	O
,	,	,	O
explaining	explain	VBG	O
why	why	WRB	O
muscle	muscle	NN	O
cells	cell	NNS	O
are	be	VBP	O
more	more	RBR	O
prone	prone	JJ	O
to	to	IN	O
statins	statins	NNP	O
side	side	JJ	O
effects	effect	NNS	O
.	.	.	O

